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The effect of wild blueberries on major endothelium-dependent vasodilation
pathways and arterial blood pressure (BP) was examined in the young adult
Spontaneously Hypertensive rat (SHR), used as a model of endothelial
dysfunction, and the Wistar Kyoto (WK) rat, with functional endothelium, used as
the control. Male SHR and WK rats were fed a control (SHR-C and WK-C), or a
wild blueberry-enriched (SHR-B and WK-B) diet for nine weeks. By the age of 21
weeks, thoracic aortae were excised and 3mm arterial rings were prepared and
immersed in Radnoti tissue baths. Rings were precontractred with phenylephrine
(Phe) (10"6M), followed by cumulative acetylcholine (Ach) doses (10"9M to 3x10"
6

M) to generate dose-response curves in the absence or in the presence of either

a nitric oxide synthase (NOS) inhibitor (L-NMMA at 10"4M), a cyclooxygenase
(COX) inhibitor (MFA at 10"5M) or both inhibitors added simultaneously. The
maximum Ach-induced vasodilation force (Fmax) and vessel sensitivity (pD2)
were determined for each treatment group.

A two-way analysis of variance (ANOVA) demonstrated no significant difference
in the Fmax between the WK-B and WK-C groups. However, wild blueberries
were found to reduce the pD2 in response to Ach in the young adult WK rat (WKB: 7.41 ± 0.02 vs. WK-C 7.49 ± 0.02, p<0.05, n=9). In the young adult SHR, wild
blueberries were shown to reduce Fmax in response to Ach (SHR-B: 92.13 ±
0.56 vs. SHR-C: 94.63 ± 0.56, p<0.05, n=10). This effect is mediated by the COX
pathway, as shown by the increased Fmax in response to Ach with the COXpathway inhibition (SHR-B: 102.17 ± 0.57 vs. SHR-C: 97.76 ± 0.57, p<0.05,
n=10). Furthermore, wild blueberries were shown to increase the pD2 of the
young adult SHR aorta, when COX and NO pathways were inhibited separately,
SHR-B: 7.72 ± 0.02 vs. SHR-C: 7.63 ± 0.02, p<0.05, n=10, and SHR-B: 7.17 ±
0.02 vs. SHR-C: 7.04 ± 0.02, p<Q.05, n=10, respectively. Finally, wild blueberries
did not have a significant effect on the systolic, diastolic or mean arterial BP in
either strain.
Hence, the effect of wild blueberries on vasodilation depends on the
physiological state of the aorta (functional vs. dysfunctional endothelium), as
shown by the differential effect upon the functional endothelium of WK rat and
dysfunctional endothelium of SHR. It is possible that the beneficial effect of wild
blueberries on Ach-induced vasodilation may be masked by the high activity of
COX-derived

vasoconstrictor

factors

in the

SHR

model of

endothelial

dysfunction. Additionally, the effect of wild blueberries on vasodilation is not
associated with blood pressure in the young adult SHR and WK rat.

Further studies are required to determine whether these observations are modelspecific or reflect a general effect of wild blueberries on vasodilation during
endothelial dysfunction.
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CHAPTER 1
INTRODUCTION
Cardiovascular disease (CVD) claims more lives each year than cancer, chronic
lower respiratory diseases, accidents, and diabetes mellitus combined, with one
in three American adults having one or more types of CVD. Furthermore, the
economic impact of CVD is not to be ignored; only for 2007, the estimated direct
and indirect cost of CVD was $431.8 billion (Rosamond et al., 2007). In patients
with all types of CVD, including coronary heart disease (CHD), peripheral arterial
disease, chronic heart failure, and stroke, the vascular endothelium is the primary
site of dysfunction (Brown et al., 2001).
Since abnormal endothelial function is an early marker of CVD, the endothelium
appears to be an ideal target for preventive therapy. Emerging evidence
suggests the important role dietary factors play in modulating endothelial function
in patients at risk and those with existing CVD. Various dietary components are
hypothesized to influence CVD risk; antioxidants and flavonoids in particular, are
favorably associated with vascular health (Brown etal., 2001).
Blueberries contain anthocyanins, polyphenols and flavonoids and have the
highest antioxidant capacity among tested fruits and vegetables (Prior et al.,
1998). Previous studies conducted in our laboratory demonstrated the positive
effect of wild blueberries on endothelial function. In a study using young male
normotensive Sprague-Dawley (SD) rats, wild blueberries incorporated into the
diet, affected the vascular smooth muscle contractile machinery by suppressing
the

a-1

adrenergic

receptor-agonist-mediated

1

contraction

through

an

endothelium-dependent pathway (Norton et al., 2005). In another study, wild
blueberry consumption altered the structure of the extracellular matrix (EC) of
male SD rat aortas, by increasing the concentration of glycosaminoglycans
(GAGs) and decreasing the sulfation of all GAG type molecules, suggesting a
possible effect of wild blueberries on endothelial and vascular smooth muscle
signal transduction pathways (Kalea et al., 2005). In addition, results of a more
recent study suggested that wild blueberries affected the endothelium-dependent
vasodilation of rat aorta by modulating cell membrane-agonist interactions in
response to acetylcholine (Ach) in both young male SD rats and spontaneously
hypertensive rats (SHR). Wild blueberries affected the endothelial-dependent
vasodilation in SHR aorta most likely, by modulating a key pathway of endothelial
function, the cyclooxygenase (COX) pathway (Clark, 2007).
In the proposed research, the effect of wild blueberries on endotheliumdependent vasodilation will be further investigated in young adult male SHRs
and their normotensive control, the Wistar Kyoto (WK) rats.
The goal of this project is to study the effect of wild blueberries on the aortic
functional properties of young adult hypertensive (SHRs) and normotensive
(WK) rats, and to further investigate the mechanism(s) by which wild blueberries
exert their action on the endothelium-mediated vasodilation of rat aorta.
The objectives are to determine:
1.

whether

wild

blueberries

affect

Ach-induced

endothelium-mediated

vasodilation in young adult, 21 weeks of age, SHR and WK rats, and

2

2. the mechanisms of wild blueberry action on the COX and nitric oxide (NO)
pathways by the use of COX and NO synthase (NOS) inhibitors, mefenamic acid
(MFA) and L-NG-mono-methyl (L-NMMA) respectively, and
3. to determine the effect of wild blueberries on blood pressure (BP) regulation
This study is unique, because it is the first ex vivo dietary study to date that
attempts to elucidate the effect of wild blueberries on endothelial function in
young

adult

hypertensive

and

normotensive

animals and

probe their

mechanisms of action on the COX and NO pathways. The SHRs will be utilized
as a model of endothelial dysfunction that by the age of 21 weeks has developed
full-blown hypertension. The WK rat will be used as a model of functional
endothelium (control). Results from this project will further clarify the relationship
between endothelial dysfunction and CVD and determine the potential use of wild
blueberries on CVD prevention and/or therapy.
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CHAPTER 2
LITERATURE REVIEW
2.1. Cardiovascular Disease and Endothelial Dysfunction
2.1.1. Endothelial Function
After the discovery of Furchgott and Zawadzki that Ach requires the presence of
endothelial cells to elicit vasodilation (Furchgott and Zawadzki, 1980), the
endothelial cell layer has gained all the more greater appreciation. The
endothelium is now considered an indispensable organ that regulates the
vascular tone and maintains the vascular homeostasis in a paracrine, endocrine
and autocrine fashion. A healthy endothelium promotes vasodilation and also has
antioxidant,

anti-inflammatory,

anticoagulant

and profibrinolytic

properties.

Additionally, leukocyte adhesion and migration, as well as vascular smooth
muscle cell (VSMC) proliferation and migration are inhibited by the endothelium
under normal physiological conditions (Bonetti et al., 2003).
The endothelium, located in the interface off the vessel wall and the blood
stream,

releases

substances

that

regulate

vasomotor

function,

trigger

inflammatory processes and affect vascular homeostasis, in response to
pressure, shear force or vasoactive factors (Endemann and Schiffrin, 2004).
The endothelium contributes to the physiological regulation of vasomotor control
through maintaining equilibrium in releasing endothelium-derived relaxing factors
(EDRF) and endothelium-derived contracting factors (EDCF). The EDRF such as
nitric oxide (NO), prostacyclin or prostaglandin l 2 (PGb) and endothelium-derived
hyperpolarizing factor (EDHF) counteract the effect of the EDCF, such as

4

endothelin-1 (ET-1), thromboxane A2 (TXA2) and prostaglandin H2 (PGH2) in
maintaining a physiological vascular tone (Vanhoutte, 2003). Two major
biochemical pathways of the endothelium that determine the vascular tone are
the NO synthesis pathway and the COX pathway, which generates both
vasodilator and vasoconstrictor prostanoids via the metabolic conversion of
arachidonic acid (AA) (Moncada and Higgs, 2006).

2.1.1.1. Vasodilators
The principal vasodilatory substance released by the endothelial cells is NO, a
free radical molecule, which was discovered to be a potent vasodilator (Vallance
et al., 1989). At the vascular level, NO, which is chemically equivalent to EDRF
(discovered by Furghott and Zawadski, 1980), mediates endothelium-dependent
relaxation of vascular smooth muscle (Ignarro et al., 1987; Palmer et al., 1987).
Nitric oxide is a key signaling molecule in physiological and pathological
processes; both NO and its reactive nitrogen species products are implicated in
all aspects of normal and disease conditions (Mollace et al., 2005). Nitric oxide is
formed in the endothelial cells from the guanine-nitrogen terminal of L-arginine,
by the constitutive endothelial NOS (eNOS, NOS III) via an oxidative reaction
that yields NO and citrulline. Endothelial NOS is Ca2+-calmodulin-dependent, i.e.
its activation depends on the intracellular concentration of calcium ions in the
endothelial cell. The activity of the enzyme requires cofactors such as
nicotinamide-adenine-dinucleotide

phosphate

(NADPH)

and

5,6,7,8-tetra-

hydrobiopterin (BH4). Endothelial NO synthase can be inhibited competitively by

5

L-arginine analogues such as NG-monomethyl-L-arginine (L-NMMA) or NG-nitro L-arginine (Vanhoutte, 2003). The identification of L-NMMA as an inhibitor of the
synthesis of NO provided the most important pharmacological tool for
investigating the presence and roles of NO in biological systems (Rees et ai,
1989).
Nitric oxide generation via the NOS pathway does not occur solely in the
vascular wall, indicating the biological significance of NO molecule in other
systems as well. So far, NO has been primarily studied with regard to
cardiovascular, nervous, and the immune system. There are three major
isoforms of NOS, originally named after the tissues in which they were first
identified: two calcium/calmodulin dependent; constitutive isoforms, eNOS and
neuronal NOS (nNOS, NOS I), and calcium-independent, inducible NOS (iNOS,
NOS II), which is expressed in macrophages and other tissues following
immunological stimulation (Moncada and Higgs, 2006).
It is now well established that eNOS is important for cardiovascular homeostasis,
vessel remodeling, and angiogenesis. Endothelial NOS cellular location favors
high local concentrations of NO in the vicinity of circulating blood cells and
vascular smooth muscle (Fulton et ai, 2001).
Nitric oxide is a major vasodilator in large arteries such as the coronary,
systemic, mesenteric, pulmonary and cerebral arteries, indicated by the finding
that NOS inhibition results in vasoconstriction and an increase in systemic
arterial pressure in both animals and humans (Vanhoutte, 2003).

6

Besides the fundamental role in vasodilation, NO inhibits VSMC growth, platelet
and leukocyte adhesion to the endothelium, and prevents the production of the
vasoconstrictor ET-1 (Vanhoutte, 2003).
Physical and humoral stimuli regulate NO production. The shear stress exerted
by blood flow on the endothelial cell is one of the main factors that determines
the local release of NO and thereby the flow-dependent vasodilation (Vanhoutte,
2003). The endogenous substances that stimulate the release of NO include
catecholamines, vasopressin, bradykinin, histamine, serotonin or adenosine
diphosphate (ADP) released by aggregating platelets, or thrombin, formed during
blood coagulation (Vanhoutte, 2003). These hormones and autocoids, activate
endothelial cell membrane receptors, coupled to different G-proteins, to induce
NO generation (Vanhoutte, 2003). Once synthesized, NO diffuses to the VSMC
and induces its relaxation via a cascade of events that starts with activation the
cytosolic enzyme soluble guanylate cyclase (sGC). Soluble GC catalyzes the
production of cyclic 3, 5-guanosine monophosphate (cGMP). Cytosolic Ca2+
removal from the cell and inhibition of the contractile apparatus follows the
activation of a cGMP-dependent protein kinase G. The action of protein kinase G
has direct influence on the phosphorylation of gap junctions and activity of
potassium and calcium channels. Phosphorylation of potassium channels causes
K+ outflow from the cell, while phosphorylated calcium channels decrease Ca2+
influx. Calcium release from calmodulin, due to the reduced cytoplasmic Ca2+concentration, leads to dephosphorylation of myosin light chain, which prevents

7

myosin head binding to actin and thereby produces relaxation of smooth muscle
(Lincoln et al., 1994).
In contrast, iNOS is calcium independent and once expressed produces NO in
large amounts for a prolonged period of time (Nathan, 1992). Inducible NOS is
thought to mediate the vast majority of pathological effects attributed to NO,
having a fundamental role in the inflammatory process (Mollace et al., 2005).
Another important vasodilator secreted by the endothelium is PGb, a major
product of arachidonic

acid (AA) metabolism

(Moncada et al., 1979).

Cyclooxygenase or prostaglandin endoperoxide synthase (PGHS) is the key
enzyme of AA conversion into prostanoids that starts with AA release from the
cell membrane phospholipids under the action of phospholipase A2 (PLA2),
followed by its conversion, first into the cyclic endoperoxide prostaglandin G2
(PGG2) and subsequently into the endoperoxide prostaglandin H2 (PGH2), with
both steps catalyzed by COX.

These unstable intermediate products of AA

metabolism are rapidly converted into the biologically active prostaglandins
PGD2, PGE2, PGF2a, PGI2 and TxA2 via specific synthases (Mollace etai, 2005).
Two distinct COX enzymes have been identified to date, COX-1, the constitutive
form found in virtually all organs, and COX-2, the inducible form detected under
inflammatory conditions in various cells (Mollace et al., 2005). The ubiquitous
COX-1 has clear physiological functions. Basal COX-1 activation is responsible
for

PGb

production

and therefore the vasodilatory,

antithrombotic

and

cytoprotective effect of this prostanoid (Moncada etai, 1976). In contrast, COX-2
is induced by proinflammatory cytokines and growth factors and expressed in
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many cells during inflammatory processes (e.g. macrophages, monocytes,
fibroblasts (Mollace etal., 2005).
Prostacyclin was first described as an EDRF in 1979 (Moncada et al., 1979). The
vasodilation and inhibition of platelet aggregation induced by PGb are correlated
with an activation of the adenylyl cyclase (AC), leading to a rise in intracellular
cyclic adenosine

monophosphate

(cAMP)

(Moncada et al., 1987). The

vasorelaxing effect of prostacyclin is determined by the specific VSMC relaxant
prostacyclin receptors (IP), which mediate an increase in cAMP. Cyclic AMP
induces vascular smooth muscle relaxation by reducing intracellular Ca2+ levels
and inhibiting of myosin light chain kinase (MLCK), the enzyme that
phosphorylates myosin and induces contraction (Narumyia et al., 1999). The
effect of NO and PGb in VSMC relaxation appears to be connected. The
increase of both cGMP and cAMP induces VSMC relaxation by reducing
intracellular Ca2+ concentrations (Lincoln et al., 1990). Cyclic GMP has been
proposed to enhance the accumulation of cAMP, due to the cGMP-mediated
inhibition of phosphodiesterase enzyme which degrades cAMP (Maurice et al.,
1991). The above mechanism also mediates the NO and PGI2 interaction for the
inhibition of platelet aggregation, with the cGMP promoting cAMP accumulation
in the platelets (Maurice and Haslam, 1990).
Prostaglandin E2 (PGE2) is another vasodilatory factor which produces smooth
muscle relaxation through interaction with the EP2 and EP4 relaxant prostanoid
receptors that are responsible for cAMP increase (Narumiya etal., 1999).

9

Yet, another factor that contributes to the endothelium-dependent relaxation
causing hyperpolarization in response to Ach and other vasodilators is the
endothelium-derived hyperpolarizing factor (EDHF), a diffusible substance,
different from NO and PGI2. The exact nature of EDHF still remains to be
determined, while several candidates such as epoxyeicosatrienoic acids (EETs),
potassium ions and hydrogen peroxide have been proposed (Feletou and
Vanhoutte, 2000).
Accumulating evidence indicates that a constant cross-talk occurs in the
endothelium between NO and prostanoids. Produced at low levels, NO appears
to regulate the COX pathway towards COX-derived vasodilator release
(Salvemini et al., 1996). There is also an indirect relationship between NO and
prostanoids in the VSMC, due to the interaction of cAMP with cGMP in the
phosphodiesterase pathway (Delpy et al., 1996). Under normal physiological
conditions, the basal release of NO and PGs by constitutive NOS and COX
respectively, has been shown to protect against vascular diseases via enhanced
vasodilation and antiplatelet activity (Mollace et al., 2005). The increase in
endogenous NO following treatment with L-arginine may enhance the vasodilator
PG level. Moreover, the enhanced release of NO may compensate for the
attenuation of prostacyclin production that follows COX-inhibition. Contrastingly,
the vasodilator PGs seem to have no capacity to modulate NO (Vassale et al.,
2003). However, in the presence of reduced NO availability, alternative
pathways, including

hyperpolarization, account for

vasodilation (Taddei et al., 1999).

10

endothelium-dependent

2.1.1.2. Vasoconstrictors
The role of the endothelium in vascular tone regulation, besides relaxing factors,
entails the generation of vasoconstricting factors (Furghott and Vanhoutte, 1989).
These vasoconstricting factors include AA metabolites such as TXA2 and PGH2,
reactive oxygen species (ROS), ET-1 and angiotensin II (Heymes etal., 2000).
The first observations of endothelium-dependent contractions were made in
canine arteries, where AA and thrombin, which are endothelium-dependent
dilators in isolated arteries, potentiated endothelium-dependent contraction
mediated by a1-adrenoreceptor agonist. This endothelium-mediated response
was attributed to the release of a diffusible factor(s) named EDCF (De Mey and
Vanhoutte, 1982). Incubation of canine veins with COX inhibitors could prevent
the endothelium-dependent contractions in response to catecholamines (Miller
and Vanhoutte, 1985). Inhibitors of COX were also shown to prevent
endothelium-dependent contractions or to normalize endothelium-dependent
relaxations in various arterial preparations (Katusic et al., 1988; Luscher and
Vanhoutte, 1986; Miyamoto et al., 1999), leading to the conclusion that COX
product(s) play a key role in the EDCF-mediated responses (Vanhoutte et al.,
2005).
Cyclooxygenase mediated contractions so far are attributed to oxygen free
radicals, mainly superoxide anions (O2), generated by the hydroperoxidase
activity of the enzyme, and prostanoids such as TXA2 or PGH2 (Vanhoutte et al.,
2005).

These

endoperoxides/

vasoconstrictor
thromboxane

prostanoids
receptors

11

act

(Narumyia

through
et

al.,

activating

the

1999). While

prostanoids act exclusively as direct vasoconstrictors, oxygen free radicals have
a direct vasoconstricting effect, possibly via PGH2 receptors, but also act
indirectly by compromising NO bioavailability (Taddei et al., 2003).
Endothelin is a potent vasoconstrictor released by the endothelium to oppose the
vasodilatory effect of NO. Endothelin contribution to vascular tone is mediated by
the endothelin receptors ETA and ETB, which trigger the phosphatidylinositol
pathway and thereby Ca2+ release from intracellular stores and vasoconstriction
(Marasciulo et al., 2006). Under physiological conditions ET-1 is highly regulated
via inhibition or stimulation from endothelium. Factors such as shear stress or
thrombin, epinephrine, angiotensin II and free radicals enhance ET-1 release,
whereas mediators such as NO, PGI2 and cGMP attenuate ET-1 generation.
However, with endothelial dysfunction and the subsequent decrease in NO
bioavailability, ET-1 synthesis, release or activity is relatively augmented
(Marasciulo etal., 2006).
Overall, vascular homeostasis depends on the balance of the bioactive factors
released by the endothelium. A dysfunction of the endothelial cell disrupts this
balance and leads to so called endothelial dysfunction (Verma and Anderson,
2002).

2.1.2. Endothelial Dysfunction
Endothelial dysfunction is a condition characterized by a shift in the actions of the
endothelium toward reduced vasodilation, proinflammatory conditions and
prothrombotic properties. It is associated with most forms of CVD, such as
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hypertension, coronary heart disease, chronic heart failure, peripheral heart
disease, diabetes and chronic renal failure (Endeman and Schiffrin, 2004).
Endothelial dysfunction, presenting a systemic nature, plays a major role in the
development and progress of the atherosclerotic processes (Bonetti et al., 2003).
Endothelial dysfunction constitutes an independent predictor of cardiovascular
events

(Vita and

Keaney, 2002), by predisposing the vessel wall to

vasoconstriction, leukocyte adherence, platelet activation, mitogenesis, oxidative
stress, thrombosis, impaired coagulation, inflammation and development of
atherosclerotic lesions (Verma and Anderson, 2002).
The dysfunction of the endothelial cells is evidenced by impairment in
endothelium-dependent relaxation, mainly due to a reduced release of EDRF,
and NO in particular, although EDCF production may also contribute (Vanhoutte,
2003). Nitric oxide reduction and the subsequent endothelial dysfunction seem to
precede any other evidence of CVD in humans with a family history of
atherosclerosis risk factors such as essential hypertension (Moncada and Higgs,
2006). Reduced activity of eNOS due to endogenous or exogenous inhibition,
reduced L-arginine

availability and reactive species that attenuate

NO

bioavailability, adversely affect NO levels (Endeman and Schiffrin, 2004). Nitric
oxide has been shown to regulate the synthesis of prostanoid vasodilators such
as PGI2, as well as vasoconstrictors such as TXA2 and PGH2, affecting the ratio
between vasodilator and vasoconstrictor prostanoids. Changes of vasodilator to
vasoconstrictor ratio are important for the development of vascular dysfunction
(Shimokawa, 1999).
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Endothelial

dysfunction

accompanied

by

the

increased

production

of

vasoconstrictor seems to play a key role in the progression of CVD (Vanhoutte et
al., 2005). Both animal and human data so far, suggest that the production of
COX-dependent EDCF is a major mechanism that leads to an impaired
availability of NO, at least in age-related or essential hypertension (Vanhoutte et
al., 2005). Additionally, increased vascular ROS play an important role in the
process leading to endothelial dysfunction (Cai and Harrison, 2000). For
instance, ROS generated by COX, reduce the biological activity of NO directly
and indirectly by contributing to lipid peroxidation, products of which might also
decrease NO synthesis and bioavailability (Keaney and Vita, 1995; Sherman et
al., 2000). Major predisposing conditions to atherosclerosis present an increased
vascular superoxide production (Cai and Harrison, 2000). Enzymes such as
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and xanthine
oxidase have been implicated in the superoxide generation in the vasculature,
especially under pathological conditions that trigger a greater activity and
expression of these enzymes (Cai and Harrision, 2000). Another source of O2" in
the vasculature is the vascular cytochrome P450 enzymes. Inhibition of these
enzymes appears to improve endothelium-dependent vasodilation mediated by
NO in patients with coronary heart disease (Cai and Harrision, 2000).
The activity of NO is deteriorated through the formation of peroxynitrite anion
(ONOO"), generated by the reaction of O2" with NO (Landmesser et al., 2004).
Peroxynitrite anion is a powerful oxidant species implicated in established clinical
conditions such as hypercholesterolemia, diabetes and coronary heart disease
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(Greenacre and Ischiropoulos, 2001). In such disorders an increased ROS
formation is observed in blood vessels. Treatment with antioxidants enhances
endothelium dependent-vasodilation in the forearm and the coronary circulation
of individuals with coronary artery disease and diabetes (Moncada and Higgs,
2006). Moreover, peroxynitrite leads to degradation of the eNOS cofactor, BH4
and therefore eNOS "uncoupling". The "uncoupling" of eNOS is the process of
activation of the reductase function of the enzyme leading to ROS formation
(Landmesser et a/., 2003), reported to occur in several pathological conditions
such as diabetes, hypercholesterolemia and hypertension (Cai and Harrison,
2000; Moncada, 2006). Additionally, ONOO" plays an important role in regulating
the COX pathway enzymes. It can increase both COX-1 and COX-2 activity,
modify AA yielding PGF2-like compounds with powerful vasoconstrictor effects
and also attenuate PGb production (Mollace et al., 2005).
In general, a reduced level of vasodilators, mainly NO, combined with an
increased vasoconstrictor activity, attributed to both COX-derived vasoconstrictor
prostanoids and ROS, disrupts the homeostasis of endothelial cell and lead to an
impairment of the endothelium dependent relaxations, which is a basic feature of
endothelial dysfunction.

2.1.2.1. Spontaneously Hypertensive Rat as a Model of Endothelial
Dysfunction
The SHR has been broadly used as a model of essential hypertension and
endothelial dysfunction not only in pharmacological studies (Luscher and
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Vanhoutte, 1986; Xiao and Pang, 1994; Yang et al., 2002), but in dietary studies
as well (Duarte et al., 2001; Machha et al., 2005; Rodriguez-lturbe et al., 2003).
The strain of SHRs was developed in 1963 from outbred WK rats (Okamoto and
Aoki, 1963). The SHR develops hypertension spontaneously with no exception at
the age of 7 to 15 weeks. The systolic blood pressure (BP) plateaus at
approximately 200 mmHg (Yamori, 1984). The age of 10 weeks in SHR is
considered as the early hypertensive stage, with a systolic BP at approximately
170 mmHg (Tanase et al., 1982). The increased peripheral vascular resistance of
the SHR is mostly determined by neurogenic mechanisms related to a disorder of
central BP regulation. Structural changes in the vasculature of SHR, due to the
increased BP and neurogenic tone, contribute to the maintenance of the
hypertension. In the SHR, VSMCs seem to be genetically predisposed to
hyperplastic growth and p-adrenergic stimulation (Yamori, 1984). Additionally,
SHRs present increased levels of noraderanline, but not of total catecholamines
(Grobecker et al., 1975), as well as an abnormal electrolyte balance (Dietz et al.,
1984). In the SHR, environmental and dietary factors can influence the degree of
hypertension (Yamori, 1984). Caloric restriction has been observed to lower BP
(Young et al., 1978), while a high salt diet seems to increase systolic BP (Adams
and Blizard, 1991).
The endothelial dysfunction and the high BP in the SHR is also attributed to
decreased NO availability, enhanced oxidative stress and an overall increased
formation of COX-derived EDCF that lead to inhibition of endothelium-dependent
vasodilation (Vanhoutte, 2003). The pharmacological concentrations of Ach
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(3x10"7 to 3xlO"5M) can cause endothelium dependent contraction in the aorta of
the SHR, but not in the normotensive rats, suggesting an impaired production
and/or diminished bioavailability of NO in essential hypertension (Luscher and
Vanhoutte, 1986). Endothelial NOS activity seems to be preserved, and even
increased in the SHR, probably as a compensatory mechanism for the increased
BP (Xiao and Pang, 1994). However, the NO bioavailability is attenuated; further
so due to an increased superoxide generation by NADPH. Therefore, the
endothelium-dependent vasodilation is impaired in the SHR (Zalba et al., 2001,
a). The reduced NO bioavailability amplifies the

endothelium-dependent

contractions (Yang etal., 2002; 2003).
Product(s) of COX pathway play a key role in vasoconstriction, since the COX
inhibitor indomethacin seems to normalize endothelium-dependent relaxations in
the aorta of the SHR (Luscher and Vanhoutte, 1986; Ito etal., 1991). Preferential
inhibitors of COX-1, but not of COX-2 prevented the endothelium-dependent
contractions to Ach (Ge et al., 1995; Yang et al., 2002). The constitutive isoform
of COX is responsible for the blunted endothelium-dependent relaxation to Ach in
the SHR aorta, suggested by the finding that COX-1 expression was significantly
greater in the aorta of adult SHRs than in that of normotensive WK controls (Ge
et al., 1995). Although indomethacin cancelled the Ach-induced endotheliumdependent contraction in the SHR, TXA2 synthase selective inhibition, did not
modulate endothelium dependent contraction, suggesting that some AA
product(s), other than TXA2, are responsible for the vascular contractions in the
SHR (Luscher and Vanhoutte, 1986). The COX-derived EDCF could be the

17

unstable endoperoxides that produce contraction by stimulating the TXA2/PGH2
receptors on the VSMC, since the inhibition of TP receptors was shown to
improve to some extent the vasodilation in the SHR (Luscher and Vanhoutte,
1986). Prostacyclin has been also implicated, at least in part, in the endotheliumdependent contractions induced by Ach in the SHR aorta. This particular effect of
PGI2 in the SHR seems to be mediated through the activation of TP receptors in
the VSMC (Gluais et al., 2005). Prostacyclin, acting as a vasoconstrictor, was
also found to be the main culprit for the endothelial dysfunction in the SHR aorta
treated with aldosterone. In the same study, other prostanoids were also involved
in the aldosterone-induced endothelial dysfunction in the WK rat (Blanco-Rivero
efa/.,2005).
Besides prostanoids, COX-derived ROS seem to contribute to the pathogenesis
of endothelial dysfunction in experimental hypertension (Katusic and Vanhoutte,
1989; Yang et al., 2002). The increased O2", may mediate Ach-induced
endothelium-dependent contractions and endothelial dysfunction in the SHR
(Kerr et al., 1999; Yang et al., 2002; Cuzocrea et al., 2004). Superoxide anions
can stimulate COX-1 to convert AA into endoperoxides, which activate TPreceptors of the vascular smooth muscle. A greater activity of COX-1 and a
greater TP-receptor response are both required for endothelium-dependent
contractions (Ge et al., 1995; 1999).
The endothelium-dependent contractions can be depressed by scavenging or
depleting superoxide anions (Yang et al., 2002; 2003). Furthermore, anti-oxidant
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dietary treatment has been shown to improve endothelial function in the SHR
(Maccha and Mustafa, 2005; Rodriguez-lturbe etal., 2003; Ulker et al., 2003).
An important factor that determines the impaired vasodilation and the
progression of endothelial dysfunction in the SHR is age. In SHR younger than
14 weeks, the endothelium-mediated vasorelaxation seems to be similar to
normotensive rats of the same age. Hence young SHRs can be considered as
normotensive before full development of hypertension (Cappelli-Bigazzi et al.,
1997). The aging effect on the old SHR and WK rat aorta is reflected through
various changes in the endothelium and smooth muscle as well. While in the
young adult SHR (12 to 14 weeks), PGH2 accounts for the reduced endotheliumdependent relaxation, in old (72 weeks) WK rat and SHR, reduced NO levels,
due to either impaired formation or increased inactivation, seem to be involved
(Kung and Luscher, 1995). Age, does not seem to affect contractions of ET-1 in
the WK rat, whereas the response is diminished in 72 week vs. 12 week-old SHR
(Kung and Luscher 1995). In 30-week adult SHRs, the reduced NO availability
induced by NADPH superoxide production seems to play a critical role in the
impaired endothelial function in comparison with the 14-week old SHR (Zalba et
al., 2001, b). Furthermore, in one year old SHR, PGb released by Ach was
shown to act as a contracting and not a relaxing factor (Gluais et al., 2005),
probably due to a decreased response of the IP receptor. In the aorta of older
than 15-week WK or SHR, IP receptor agonists cannot evoke relaxations (Levy,
1980; Rapoport and Williams, 1996). The expression of the IP receptor
decreases with age, but in the SHR the receptor is less expressed than in the
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WK rat at any age (Numaguchi et al., 1999). The endothelium-dependent
contraction in response to Phe is increased, whereas the endothelium-dependent
relaxation is reduced in aging SHR (12 weeks vs. 16 months). Alterations in the
sGC-NO pathway are involved in the age-related changes in vascular
contractions and relaxations. However, long-term treatment with vitamins E and
C or tempol, a superoxide dismutase (SOD) mimetic, was shown to partially
reverse the age-related inhibition of vascular relaxation (Payne et al., 2003).
Acetylcholine-mediated vasorelaxation, even after treatment with a non-selective
COX inhibitor, did not differ significantly among WK rats and SHR between 3 to
6 months of age, while the release of COX-dependent vasoconstrictors occurred
only in vessels of aged (12 to 25 months) normotensive or SHR animals and in
response to higher concentrations of Ach (Koga et al., 1989). Treatment with
simvastatin, an inhibitor of the rate-limiting enzyme in the cholesterol
biosynthesis, was associated with reduced COX-1, but not COX-2 expression in
the aorta from aged WK rat and SHR. The capacity of the aged aorta to release
COX-2-derived vasoconstrictors was reduced, whereas PGb release was not
altered with the simvastatin treatment (de Sotomayor et al., 2005). In support of
the above finding, COX-1 expression was significantly increased in aortas of the
older WK rats and SHRs (Ge et al., 1995; 1999).
Therefore, the aging process in the SHR is characterized by a further
deterioration of endothelial dysfunction, adversely affecting NO bioavailability and
shifting the COX pathway effect on vasomotion towards an increased
vasoconstrictor and a reduced vasodilator activity.
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Despite the complexity of the endothelial defects of the SHR, this animal model is
considered suitable to study endothelial dysfunction and essential hypertension,
due to the great similarity the SHR shows with humans with essential
hypertension.

2.1.2.2. Endothelial Dysfunction in Essential Hypertension
Essential or primary hypertension is a multifactorial and complex disease not
well-understood so far. However, a strong association of essential hypertension
with endothelial dysfunction has been documented (John and Schmieder, 2000).
Similar to experimental hypertension, endothelium NO-dependent vasodilation is
impaired in human hypertension as well. Administration of L-arginine can
increase the vasodilating effect of Ach in normotensive patients, but not in
essential hypertensive patients (Taddei et ai, 1997). In addition L-NMMA can
blunt the response to Ach in normotensive, but not in hypertensive patients
(Panza et ai, 1995). Endothelial dysfunction is attributable not only to a defect in
the L-arginine-NO pathway (Taddei et ai, 1997), but to the production of COXdependent EDCF(s) as well (Taddei et ai, 1998).

In essential hypertensive

patients, the vasodilation to Ach is blunted and not affected by inhibition of NO
synthase (Dohi et ai, 1990). However, indomethacin was shown to increase and
almost normalize the vasodilator response to Ach in these patients (Taddei et ai,
1998). These findings demonstrate that in essential human hypertension,
vasoconstrictor products of COX are mainly responsible for the abnormal
reaction to endothelium-dependent vasodilators (Vanhoutte et ai,
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2005).

However, the production of COX-derived EDCF(s) may not be implicated in all
forms of hypertension since COX inhibitors were shown to improve vasodilation
in human subjects with essential hypertension, but not in secondary forms of
hypertension (Taddei and Salvetti, 2002).
Oxidative stress seems to account for the impaired NO availability that
characterizes the endothelial dysfunction associated with human essential
hypertension. The antioxidant vitamin C was shown to improve the endotheliumdependent

vasodilation

by

restoring

NO

availability

in

the

forearm

microcirculation of essential hypertensive patients (Taddei etal., 1998).
The impaired endothelium-dependent vasodilation in essential hypertension may
not necessarily be a causal mechanism responsible for the development or
maintenance of increased BP. Available evidence seems to indicate dissociation
between the degree of endothelial dysfunction and arterial BP values (John and
Schmieder, 2000). Impaired endothelium-dependent vasodilation appears to be
at least partially genetically pre-determined (Rossi et al., 2003). Moreover it
seems that there is no correlation between BP values and endotheliumdependent vasodilation (Panza et al., 1993). Finally, BP reduction per se is not
associated with improvement of endothelium-dependent vasodilation (Panza et
al., 1993; Taddei and Salvetti, 2002). Therefore, endothelial dysfunction,
although associated with essential hypertension, may not be related to
hemodynamic load.
On the other hand, endothelial dysfunction is not specific to essential
hypertension,

but

commonly

observed
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in

connection

with

the

major

cardiovascular risk factors (Vita et al., 1990; Taddei and Salvetti, 2002). The
exact relationship between endothelial dysfunction and cardiovascular events in
essential hypertension patients remains to be elucidated (Taddei et al., 2003).
Independent of essential hypertension, a continuous impairment of the
endothelium occurs with age. In normotensive human subjects a defect in the
NO pathway seems to be the main cause of age-related endothelium dysfunction
as EDCF contribution is minimal up to 60 years of age. Above the age of 60,
EDCF seems to participate in the process, while the defect on the NO pathway is
aggravated (Taddei et al., 1997). In contrast, the contribution of COX-derived
vasoconstrictors to the endothelium impairment starts at an earlier age (31-45
years) and increases even more with age in humans with essential hypertension
(Taddei et al., 1997).
Vitamin C and indomethacin improved Ach-induced vasodilation in normotensive
humans above the age of 60 years, indicating that COX-derived ROS contribute
to the EDCF-mediated endothelium responses in aging and hypertension (Taddei
et al., 2001). The aging blood vessel wall is characterized by the production of
COX-derived EDCF, but essential hypertension causes an earlier onset and a
greater progress of the dysfunctional endothelium (Vahoutte et al., 2005).
Decreased NO synthesis was also shown in aged human umbilical vein
endothelial cells (HUVECs), where upregulation of eNOS expression induced by
shear stress was impaired. Furthermore, aging of the endothelial cells resulted in
enhanced apoptosis due to the loss of eNOS expression (Hoffmann et al., 2001).
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Overall, a progressive reduced expression and activity of eNOS, as well as
increased release of ROS and COX-derived contracting prostanoids alters the
equilibrium between vasorelaxing and vasoconstricting endothelium-derived
factors and results in the age-related endothelial dysfunction (Matz and
Andriantsitohaina, 2003).

2.2. Wild Blueberry Composition and Bioactive Components
Wild blueberries (Vaccinium angustifolium) have exhibited one of the highest
recorded in vitro antioxidant capacity among various fruits and vegetables tested
(Prior et al., 1998). Also, the wild blueberry has a higher in vitro antioxidant
capacity than the cultivated highbush blueberry (Vaccinium corymbosum) (Kalt et
al., 2001). Consumption of blueberries has been associated with an increase of
total serum anthocyanins and serum antioxidant status in human subjects
(Mazza et al., 2002; Kay and Holub, 2002). Prior et al. (1998) confirmed a direct
relationship between the total oxygen radical absorbance capacity (ORAC) and
the total phenolic content of several Vaccinium species in vitro (Prior et al.,
1998). The ORAC assay is a method developed to quantify the total antioxidant
activity of a biological sample (Cao et al., 1993).
Anthocyanins are among the most abundant flavonoids in wild blueberries (Kalt
and McDonald, 1996). Five major anthocyanins were identified in the lowbush
blueberry: malvidin, delphinidin, cyanidin, petunidin and peonidin (Table 2.1).
Anthocyanins in wild blueberry are found as 3-glucosides, 3-galactosides and 3arabinosides (Gao and Mazza, 1995). Chlorogenic acid is the major phenolic
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acid in lowbush blueberries, while other major organic acids include citric, malic
and quinic acids (Kalt and McDonald, 1996). The major flavonols detected in
blueberries are quercetin and myricetin (Hakkinen et al., 1999) (Table 2.1). Wild
blueberries also contain proanthocyanins, which are higher molecular weight
tannin components, shown to inhibit the initiation stage of chemically induced
carcinogenesis (Smith et al., 2000). The stilbene compound resveratrol is also
found in lowbush blueberries (863 ng/g dry weight) (Rimando et al., 2004).
According to Bushway et al. (1983), wild blueberries contain a variety of vitamins
and minerals. A 100g wet weight portion of wild blueberries offers approximately
7, 3, 2, 11 and 2% of the dietary reference intake (DRI) for niacin, riboflavin,
thiamin, vitamin C and A respectively. Wth regards to mineral composition, the
eleven elements of blueberries are calcium, potassium, magnesium, phosphorus,
aluminium, boron, copper, iron, manganese, sodium and zinc. The DRI for these
minerals are 3% or less, with the exception of manganese, which is found in wild
blueberry composition at levels of 50-100% of the DRI, making them an excellent
source of manganese (Bushway etal., 1983).
In humans, the daily intake of the total antioxidants from fruit and vegetables was
significantly correlated with the fasting plasma antioxidant capacity (ORAC) (Cao
et al., 1998). Since wild blueberries are relatively low in antioxidant vitamins and
minerals (Bushway et al., 1983), their in vitro antioxidant capacity has been
attributed to their high concentration of phenolic compounds, particularly
anthocyanins (Kalt etal., 1999; Prior etal., 1998; Smith etal., 2000).
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Table 2.1. Flavonoid Content of Blueberries
49.21
Anthocyanidins Malvidin
Delphinidin
29.54
Cyanidin
15.02
Petunidin
11.73
Peonidin
7.05
Quercetin
Flavonols
3.11
Myricetin
0.82
Adapted from USDA database for the flavonoid content of selected foods, 2003
(mg/100 g edible portion)

2.3. Flavonoids
2.3.1. Flavonoid Structure
Flavonoids comprise the most common and widely distributed group of the
polyphenolic compounds that occur naturally in plants. The common structure of
flavonoids consists of two aromatic benzene rings (A and B ring) linked through a
three carbon oxygenated heterocycle (C ring) (Figure 2.1) (Bravo, 1998).
Figure 2.1. Basic Flavonoid Structure (flavan nucleus)
3'

(Adapted from Erdman et a/., 2007)
Variations in the heterocyclic ring C account for the different classes of
flavonoids, namely flavonols, flavones, catechins (flavan-3-ols), flavanones,
anthocyanidins and isoflavonoids. Additionally, the basic structure of the
flavonoid molecule allows for a wide range of substitutions in the benzene rings,
A and B, within each class of flavonoids: phenolic hydroxyls, O-sugars, methoxy

26

groups, sulfates and glucorunides (Hollman and Katan, 1999). The hydroxyl
groups of all rings are potential sites for linkage to carbohydrates. Flavonoids that
have at least one sugar molecule comprise the flavonoid glycosides, whereas
those that are not bound to a sugar molecule are called aglycones. Attachment of
acetyl and malonyl groups to the sugar conjugates further increases the
structural complexity of the flavonoids (Beecher, 2003). The most common form
of flavonoids found in plants is the glycoside derivatives (Bravo, 1998). Glucose
is the most typical glycosidic unit; other sugar units include glucorhamnose,
galactose, arabinose and rhamnose (Cook and Samman, 1996).
The chemical structure of flavonoids affects their metabolism and biological
activity (Heim et al., 2002). Sugar molecules or other functional groups attached
to the basic flavonoid structure or flavan nucleus affect flavonoid absorption and
metabolism (Hollman and Katan, 1999). The radical scavenging and chelating
activities are influenced by the number, position and types of substitution
molecules of the basic flavan nucleus (Heim et al., 2002).
The antioxidant activity of flavonoids is mainly attributed to the presence of
phenolic hydroxyl groups (Kandaswami and Middleton, 1994). The B-ring
hydroxyl group in particular is the most significant factor for ROS scavenging
ability. Additionally, the resonance of electrons between the A and B rings is an
important determinant of antioxidant and other biological activities of flavonoids
(Burda and Oleszek, 2001). Recent findings suggest that the structural features
required for antioxidant activity may be unrelated to those needed for antiinflammatory activity of compounds such as quercetin and related flavonoids
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(Loke et a/., 2008). The 2,3 double bond of the C-ring is essential for leukotriene
inhibitory activity (Loke et a/., 2008), as well as inhibition of adhesion molecule
expression in endothelial cells (Lotito and Frei, 2006) whereas the absence of the
C-3 hydroxyl group significantly reduces antioxidant properties (Loke et a/.,
2008).
Anthocyanins are distinguished from other flavonoids as a separate class due
to their ability to form flavylium cations (Prior et al., 2006) (Figure 2.2).
Figure 2.2. Basic Anthocyanin Structure (flavylium cation)

(Adapted from Prior et al., 2006)
Anthocyanins (Greek: anthos = flower and kyanos = blue), are the water soluble
colorful compounds that provide the red, purple and blue colors of many
vegetables and fruits. The structural variations of anthocyanins stem from
differences in the number of hydroxyl groups, the degree of methylation of these
hydroxyl groups, the nature and the number of the sugar moiety attached to the
phenolic (aglycone) molecule and the position of attachment, and finally the
nature and the number of aliphatic or aromatic acids attached to the sugars
(Kong et al., 2003) (Table 2.2). The basic anthocyanin structure is comprised of
the aglycone part, named anthocyanidin, and a sugar moiety mainly attached at
the 3-position on the C-ring or the 5, 7-position on the A-ring (Prior et al., 2006).
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Table 2.2. Chemical Structure of 1the Major Blueberry
Position/
3
5
7
3'
4'
6
Anthocyanin
OH
OH
Cyanidin
H
OH
OH
OH
OH
Delphinidin
OH
H
OH
OH
OH
Malvidin
OH
OH
H
OH OMe OH
OH
OH
Peonidin
H
OH OMe OH
OH
OH
Petunidin
H
OH OMe OH
Adapted from Kongefa/., 2003
OH: hydroxyl; H: hydrogen; OMe: methyl

Antho
5'
H
OH
OMe
H
OH

Glucose, galactose, arabinose, rhamnose and xylose are the most common
sugars linked to the anthocyanidins as mono-, di- or tri-saccharide forms. Among
the 17 anthocyanidins found in nature, the six most widely distributed are
cyanidin (Cy), delphinidin (Dp), petunidin (Pt), peonidin (Pn), pelargonidin (Pg)
and malvidin (Mv) (Prior et al., 2006).
In comparison with other flavonoid compounds anthocyanins show a more
complex biochemistry. In aqueous solutions anthocyanins occur in a dynamic
equilibrium of four different molecular forms (flavylium cation, quinoidal base,
hemiacetal base and chalcone), the amounts of which vary according to solution,
pH and structure of the anthocyanins. Anthocyanins exist in the stable flavylium
cation form only when the pH < 2. This unique feature is a key factor that affects
absorption, bioavailability, metabolism, and therefore the biological activity of
anthocyanins (Prior et al., 2006).
The biological effects of anthocyanins are determined by their structural
characteristics. Delphinidin and cyanidin, but not pelargonidin, peonidin or
malvidin, inhibit lipopolysacharide-induced COX-2 expression (Hou et al., 2005).
The inhibitory actions and the anti-inflammatory properties of delphinidin and
cyanidin seem to be related to the orffro-dihydroxyphenyl structure of these
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anthocyanidins (Hou et a/., 2005).

Delphinidin and cyanidin, both having a

hydroxyl residue at the 3' position, inhibited platelet derived growth factor A3 "
(PDGFAB)

induced vascular endothelial growth factor (VEGF) expression in the

VSMC, but malvidin and peonidin had no effect. In the same study delphinidin
and cyanidin directly scavenged ROS and prevented the PDGFAB-induced
formation of ROS in the VSMC, whereas malvidin and peonidin did not scavenge
ROS, but prevented their cellular formation (Oak et a/., 2006).
There is great research interest on the structure-activity relationships of flavonoid
compounds and flavonoid activity in general, as well as health benefits of
flavonoid-rich foods, as flavonoids are one of the most widely distributed groups
of plant metabolites and constitute an important part of the human diet (Bravo,
1998).

2.3.2. Dietary Intake of Flavonoids
The primary dietary sources of flavonoids include tea, red wine, fruits and
berries, cocoa, chocolate, vegetables and legumes (Manach et al., 2004). Their
wide distribution in food sources and the variations in the flavonoid content in a
given food, as well as the structural diversity of plant flavonoids complicate the
assessment of their dietary intake (Scalbert and Williamson, 2000). Data from
Western European studies show that total flavonoid intake varies considerably in
western populations, with crude estimates of average intake ranging between 65
to 250mg/day (Erdman et al., 2007). Estimates for individual classes of flavonoid
also

show

great

variation

among

different

30

populations.

For

instance,

anthocyanidin consumption in Germany is estimated to be 6.5 mg/day (Linseisen
et al., 1997). In the US anthocyanidin consumption is estimated to be 1.3 mg/day
(Chun et al. 2007) and the average proanthocyanidin intake is 58 mg (Gu et al.,
2004). The daily intake of anthocyanins in the US, according to the data for
anthocyanin concentration and updated food intake from NHANES 2001-2002, is
estimated to be 12.5 mg/day/person (Wu era/., 2006).
The average dietary intake of polyphenols in the US was estimated by Kuhnau
(1976) to be 1g/day, exceeding the intake of other common antioxidants such as
vitamin C (90 mg/day), vitamin E (12 mg/day) and carotenoids (5mg/day). The
main sources of polyphenols evaluated for this study were fruits, tea, coffee and
wine (Kuhnau, 1976). These data continue to serve as a reference for daily
polyphenol intake, even though they are now known to be rather incomplete and
inaccurate. Progress has been made in the development of polyphenol profiles of
certain foods. However, the accurate determination of intake is not feasible due
to lack of a comprehensive food composition database (Erdman et al., 2007).

2.3.3. Flavonoid Absorption, Metabolism and Bioavailability
The rate of absorption and bioavailability of the ingested flavonoids determines
their biological functions. The extent to which their metabolism interferes with the
antioxidant capacity further dictates their health effects (Hollman and Katan,
1999). In general, bioavailability varies widely among polyphenols, with several
factors, such as the dietary source, the food matrix or background diet and the

31

structure of the compound, explaining the variation of bioavailability among
different polyphenols compounds (Manach etal., 2005).
At the cellular level, the absorption mechanism of a certain flavonoid is
determined by its structure. Flavonoids naturally occur mostly in a glycosylated
state. The glycosylated flavonoids can be hydrolyzed at the brush border and
subsequently the aglycones diffuse across the cell membrane. The glycosylated
form may also enter the enterocyte via a sodium-dependent glucose transporter.
In the enterocyte, the cytosolic (3-glycosidase cleaves the carbohydrate off the
flavonoid (Tapiero etal., 2002).
In the intestinal cells, after hydrolysis to the free aglycone, flavonoids are
conjugated by methylation, sulfation, glucuronidation or a combination, and
bound to albumin for transport to the liver. Further methylation or sulfation of the
flavonoid may occur in the liver (Harborne and Williams, 2000). Methylation,
sulfation, glucuronidation or a combination are all conjugation reactions that may
occur after hydrolysis of a glycosidic flavonoid. The involved metabolic pathways
normally follow drug metabolism patterns and are controlled by the distribution
and specificity of the catalyzing enzymes. The end result is altered biological
properties of the circulating metabolites. After ingestion, flavonoids are quickly
eliminated via urine or bile excretion (Scalbert and Williamson, 2000). However,
the half-life of conjugated flavonoids is rather long, suggesting that regular
flavonoid intake may result in accumulation of these metabolites over time
(Young et al., 1999). Microorganisms in the colon can hydrolyze and extensively
degrade dietary flavonoids (Kuhnau, 1976). However, some of the anthocyanin
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glycosides can be absorbed and excreted unchanged in their glycosidic form
(Cao etal., 2001, Mazza etal., 2002; Kahkonen and Heinonen, 2003).
The presence of anthocyanins, rutin and quercetin glycosides was detected in
human plasma, confirming that flavonoids can be absorbed in their glycosylated
form in vivo (Paganga and Rice-Evans, 1997). Oral administration of quercetin
resulted in detectable levels of the flavonoid and its derivatives in the plasma and
urine of human subjects receiving 200 ml or more of grape juice. In mice, the
cumulative amounts of quercetin excreted in the urine after concentrated grape
juice administration for four days were 0.7% of the ingested dose (Meng et al.,
2004). In pigs, quercetin and quercetin glycosides were shown to be metabolized
in the intestinal mucosa. Total bioavailability of quercetin glycoside was higher
than the aglycone. However, total bioavailability of quercetin glycoside is
dependent on diet composition, as shown by enhanced absorption of the
glycoside when meat was incorporated into the animal diet (Cermak et al., 2003).
Bioavailability of several flavonoids from almond skins was also investigated in
hamsters. All five flavonoids

from

almond skin

(catechin, epicatechin,

kaempherol, quercetin and isorhamnetin) were detected in hamster plasma and
liver (Chen et al., 2005).
The absorption and bioavailability of the different classes of flavonoids shows a
great variation. Most of the research to date suggests that the anthocyanins are
the least absorbed flavonoids. However, the low anthocyanin bioavailability
observed in various human studies could have been underestimated. On the one
hand, some important metabolites might have been ignored or the methods used
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for analysis might need to be optimized (Manach et al., 2005). Several studies
indicate that anthocyanin absorption starts from the stomach (Ichiyanagi et al.,
2004; Ichiyanagi et al., 2006; Felgines et al., 2006). Similar to other flavonoids,
the absorption of anthocyanins is greatly affected by the structure of the aglycone
and the sugar attached. More free hydroxyl groups and less methoxyl groups can
decrease absorption, whereas glucose seems to increase absorption versus
galactose (Yi etal., 2006).
The individual anthocyanin content of the dietary source and the form of
administration also affect their absorption and bioavailability. A lower rate of
anthocyanin excretion after blueberry vs. elderberry consumption was observed
in elderly women, although the total amount of anthocyanins consumed was
nearly the same (Wu et al., 2002). The administrated dose is another factor to
consider in anthocyanin bioavailability. The 24 h excretion of red cabbage
anthocyanins increased with higher dose, whereas the urinary recovery of intact
anthocyanins decreased, also in a dose-dependent manner (Charron et al.,
2007). Metabolic conversion in the liver or kidney accounts for the difference
between anthocyanin profiles in these organs and blood plasma, after bilberry
extract administration in rats (Ichiyanagi et al., 2006).
Anthocyanins that are not absorbed in the stomach or the small intestine may be
transferred to the colon, whereas, absorbed anthocyanins can also reach the
colon through

bile excretion.

Extensive degradation

and

hydrolysis

of

anthocyanins by the intestinal microflora has been shown in vitro (Aura et al.,
2005; Keppler et al., 2005). The anthocyanin metabolites produced by the

34

intestinal microflora are likely to contribute to the biological effects of the
anthocyanins, but they are often overlooked (Prior etal., 2006). For instance, in a
study by Tsuda et al., (1999) it was proposed that cyanidin-3-O-P-D-glucoside
(C3G) administered orally in rats is first hydrolyzed in the intestine by (3glucosidase and the aglycone part produced (cyanidin) is degraded to
protocatechuic acid, which may have a higher antioxidant activity (Tsuda et al.,
1999). In a recent study in humans, protocatechuic acid was found to be the
major metabolite of cyanidin glycosides from blood orange juice, accounting for
approximately 73% of the ingested dose. Hence, it was proposed that
protocatechuic acid may be responsible for the health effects attributed to
cyanidin intake (Vitaglione etal., 2007).
It is also noteworthy that blueberry and blackberry anthocyanins can cross the
blood-brain barrier. Anthocyanins from blueberry supplementation were detected
in different brain regions related to learning and memory (Andres-Lacueva et al.,
2005), while both native and methylated anthocyanins from blackberry were
shown to be transported from the blood to the brain tissue (Talavera et al., 2005).
A profound knowledge and understanding of the absorption, metabolism and
bioavailability of anthocyanins and flavonoids in general can substantially
contribute to clarify the role these bioactive compounds play in health and
disease. Additional research studies relating the results of in vitro studies with the
actual in vivo effects and acclaimed health benefits of flavonoids are needed.
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In general, flavonoids are known to protect health in several ways due to their
antioxidant, anti-inflammatory,

antiallergic,

hepatoprotective,

antithrombotic,

antiviral, and anticarcinogenic activities (Middleton etal., 2000).
Most flavonoid-related health claims are based on their antioxidant properties.
This is also the case for cardiovascular health, since oxidative stress is an
important determinant of CVD.

2.3.4. Flavonoids and Cardiovascular Health
Oxidative stress induced by ROS plays a causative role in various CVDs such as
atherosclerosis, ischemic heart disease, hypertension, cardiomyopathies, cardiac
hypertrophy and congestive heart failure (Kukreja and Hess, 1992).
In the SHR, long term consumption of an antioxidant diet enriched with vitamin E
and C, zinc and selenium, was shown to reduce oxidative stress and improve
hypertension (Rodriguez-lturbe et al., 2003). Additionally, antioxidant treatment
with vitamins E and C was shown to reverse the impaired endotheliumdependent vascular relaxation in the SHR. The effects of these antioxidant
vitamins were associated with enhanced eNOS activity and increased NO
generation, as well as reduced NADPH activity and O2" production (Ulker et al.,
2003). However, the existing scientific evidence does not justify routine use of
antioxidant supplements for prevention or treatment of CVD in humans, as more
research is needed to clarify the discrepancies between randomized clinical trials
and population studies. Instead of antioxidant supplementation, consumption of
food sources such as fruits, vegetables, whole grains and nuts that are rich in
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antioxidants and other cardioprotective nutrients is recommended (Kris-Etherton
efa/.,2004).
The Women's Health Study revealed a lower risk of CVD, and especially,
myocardial infarction, for women with higher fruit and vegetable consumption (Liu
et al., 2000). A high fruit, berry and vegetable intake was also associated with
reduced CVD risk factors and overall mortality in men (Rissanen et a/., 2003).
Therefore, increased fruit and vegetable consumption is considered a primary
preventive measure against CVD. Many commonly consumed fruits and
vegetables, as well as grains, herbal products and beverages, contain significant
amounts of phenolic compounds. The relationship between foods rich in
flavonoids, such as tea, berries, cocoa, chocolate and wine, and CVD has been
examined by epidemiological and experimental studies that overall suggest a
protective role of flavonoids (Erdman et a/., 2007). The association between
flavonoid intake and CHD assessed in a prospective cohort study revealed a
much lower cardiovascular risk in individuals with the highest flavonoid intake
(Hertog et al., 1993). Furthermore, Finish women and men with lower flavonoid
consumption over a 20-year period were shown to have higher CHD risk (Knekt
et al., 1996). Flavonoids demonstrate protective effects against the initiation and
progression of atherosclerosis. The "French paradox" originally described in 1979
(Renaud and de Lorgeril, 1992), resulted in many studies of grape flavonoids,
followed later on by studies of tea, chocolate or pomegranate (Erdman et al.,
2007). The "paradox" was that the French had a much lower CHD mortality rate,
despite a higher consumption of saturated fat. Hence, it was postulated that the
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daily consumption of red wine with meals provides cardiovascular protection. The
flavonoids from red wine, particularly flavan-3-ols, anthocyanins, flavonols and
proanthocyanidins, and not solely the alcohol, are now considered the primary
protective components (Erdman et a/., 2007). Red wine polyphenols are shown
to protect against oxidative stress, platelet aggregation and thrombogenesis.
With regard to blood vessels, these compounds are powerful vasodilators and
play an important role in preservation of endothelium integrity by inhibiting
endothelial and muscle cell proliferation and migration, and angiogenesis
processes (Cordova etal., 2005).
Other foods or juices rich in polyphenols have also been shown to have
beneficial effect on various factors related to CVD including LDL-oxidation,
platelet activity or inflammation (Stein et a/., 1999; Aviram et ai, 2004; Demrow
etal., 1995; Pearson etal., 1999; Fuhrman etal., 2005; Freedman etal., 2001;
lijima et ai, 2002; Holt et ai, 2006; Murphy et ai, 2003; Youdim et ai, 2000;
Youdim et ai, 2002; Bagchi et ai, 2004). Short term ingestion of purple grape
juice,

which

contains

flavan-3-ols,

flavonols,

anthocyanins

and

proanthocyanidins, improved endothelial function and reduced LDL susceptibility
oxidation in patients with established CAD (Stein et ai,

1999). Similarly,

pomegranate juice, which is rich in specific flavonoids such as punicalagin and
anthocyanins, was shown to have a protective effect against the atherosclerotic
process. Long term pomegranate juice intake by patients with carotid artery
stenosis reduced LDL oxidation, but also BP and intima-media thickness of the
carotid artery; an effect attributed to the potent antioxidant properties of the juice
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flavonoids (Aviram et a/., 2004). Red wine was shown to inhibit in vivo plateletmediated experimental coronary thrombosis, whereas equal amounts of pure
alcohol or alcohol-free grape juice had no effect (Demrow et al., 1995). Apple
juice was shown to inhibit in vitro copper catalyzed human LDL oxidation
(Pearson et a/., 1999). Incubation of macrophages with pomegranate juice
caused a significant reduction in cellular uptake of oxidized LDL and cholesterol
biosynthesis, as well as lower levels of cellular oxidative stress (Fuhrman et al.,
2005). Oral supplementation by healthy volunteers for two weeks, and in vitro
incubation of platelets with purple grape juice, were shown to decrease platelet
aggregation and superoxide production and to increase platelet-derived NO
release. The observed effect was dose-dependent, related to partial inhibition of
protein kinase C stimulation and attributed to antioxidant and/or a direct effect of
selected flavonoids (Freedman et al., 2001). Grape flavonoids can also inhibit
the abnormal proliferation of VSMCs, a process involved in atheroma
development and intimal thickening. Additionally, platelet-derived growth factorBB (PDGF-BB) and the subsequent migration of VSMC was inhibited by grape
flavonoids through inactivation of the phosphatidylinositol 3-kinase (PI3K) and
p38 mitogen activated protein kinase (MAPK) pathway (lijima et al., 2002). The
consumption of flavonoid-rich cocoa and chocolate has been associated with a
reduction in platelet activity (Holt et al., 2006). Supplementation for 28 days with
cocoa flavanols and related procyanidin oligomers significantly increased plasma
epicatechin and catechin concentrations and decreased in vivo human platelet
activation and aggregation (Murphy et al., 2003). Incubation of red blood cells
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with blueberry anthocyanins was found to significantly enhance cell resistance to
ROS production (Youdim et al., 2000). The protective effect of anthocyanins
against ROS was also observed in vivo after oral supplementation in rats
(Youdim et al., 2000). Blueberry and cranberry polyphenols were able to enter
endothelial cells and thereby reduce cell vulnerability to increased oxidative
stress at both the membrane and cytosol level (Youdim et al., 2002). A reduction
of tumor necrosis factor-a (TNF-a)-induced upregulation of inflammatory
mediators, such as interleukin-8 (IL-8), monocyte chemoattractant protein-1
(MCP-1) and intercellular adhesion molecule-1 (ICAM-1), was also observed in
this in vitro study (Youdim et al., 2002). These inflammatory mediators are
involved in the recruitment of leukocytes to sites of damage or inflammation
along the endothelium (Youdim et al., 2002). An anthocyanin-rich berry extract
cocktail from wild blueberry, bilberry, cranberry, elderberry, raspberry seeds and
strawberry tested in vitro was shown to possess antioxidant, antiangiogenic and
anticarcinogenic properties (Bagchi et al., 2004).
Individual flavonoids appear to act upon several enzymatic systems related to the
development of CVD in a fashion presumably dictated by their structural
characteristics (Gryglewski et al., 1987; Loke et al., 2008; Chung et al., 1993;
Hou et al., 2005; Lamy et al., 2006; Oak et al., 2006; Adhikari et al., 2005; Yan et
al., 2002; Serraino et al., 2003; Rechner and Croner, 2005). The flavonols,
quercetin and rutin, as well as the flavanes, cyanidol and meciadonol, inhibited
platelet

lipoxygenase

activity,

but

only

quercetin

and

rutin

inhibited

cyclooxygenase activity. The two flavonols but not the two flavanes, dispersed
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platelet thrombi adherent to the rabbit aortic endothelium and prevented platelet
aggregation (Gryglewski et al., 1987). At least two of the major in vivo
metabolites of quercetin were shown to retain significant inhibitory activity of proinflammatory eicosanoids such as PGE2 and leukotriene B4 (LTB4) derived from
the COX and lipoxygenase enzymatic pathways respectively (Loke et al., 2008).
Additionally, quercetin and related compounds were shown to inhibit platelet
aggregation, while quercetin also showed vasorelaxant action in the thoracic rat
aorta (Chung et al., 1993). In a recent study, delphinidin and cyanidin, but not
pelargonidin, peonidin or malvidin, inhibited lipopolysacharide-induced COX-2
expression. The orf/?o-dihydroxyphenyl structure of anthocyanidins seems to be
related

to

the

inhibitory

actions

and

the

anti-inflammatory

properties.

Furthermore, delphinidin, the most potent inhibitor among the anthocyanidins
tested, suppressed COX-2 by blocking several MAPK-mediated pathways (Hou
et al., 2005). Delphinidin was also found to be the most potent inhibitor of
vascular endothelial growth factor (VEGF) receptor phosphorylation in vitro and
in vivo among six isolated anthocyanins (cyanidin, delphinidin, pelargonidin,
peonidin and petunidin) (Lamy et al., 2006). Delphinidin and cyanidin, both
having a hydroxyl residue at the 3' position, inhibited platelet-derived growth
factor

AB " (PDGFAB)

induced VEGF expression by preventing activation of p38

MAPK and C-Jun N-terminal kinase (JNK) in the VSMC. In the same study, red
wine polyphenols, delphinidin and cyanidin directly scavenged ROS and
prevented the

PDGFAB

-induced formation of ROS in the VSMC, whereas

malvidin and peonidin did not scavenge ROS, but prevented their cellular
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formation (Oak et al., 2006). Cyanidin, cyanidin 3-galactoside and cyanidin 3glucoside from Amelanchier fruits were shown to inhibit in vitro COX-1 and -2, as
well as lipid peroxidation in a dose-dependent manner (Adhikari et al., 2005).
Cyanidin-3 galactoside and several quercetin glycosides isolated from cranberry
were found to possess comparable antioxidant activity to vitamin E. However, the
capacity of cyanidin-3-galactoside and free quercetin to prevent Cu2+ catalyzed
LDL oxidation was superior to vitamin E (Yan et al., 2002). Cyanidin-3-Oglucoside from blackberry juice had a protective in vitro effect against endothelial
dysfunction and vascular failure, induced by peroxynitrite. By scavenging the free
radical, cyanidin-3-O-glucoside reduced the peroxynitrite-induced suppression of
mitochondrial respiration, DNA damage and the nuclear enzyme poly (ADPribose) synthase (PARS) activation in HUVECs. Energy depletion and cellular
injury is the end result of massive ADP-ribosylation of nuclear proteins by PARS
(Serraino et al., 2003). Anthocyanins such as delphinidin and cyanidin as well as
various colonic metabolites of a representative phenolic mixture were also shown
to inhibit in vitro platelet function (Rechner and Croner, 2005).
The research evidence for the cardioprotective effects of flavonoid-rich foods as
well as their individual bioactive compounds is mounting and promising, so is the
evidence for the benefits of flavonoids on vasomotor function more specifically.

2.3.5. Flavonoids and Vasomotor Function
Flavonoid-rich foods and isolated flavonoids have been shown to have a positive
effect on endothelium-dependent vasodilation and BP in both in vitro and in vivo
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studies. A series of dietary ex vivo studies on the wild blueberry fruit conducted in
Dr. Klimis-Zacas' laboratory have shown the potential of wild blueberries in
protecting the endothelial function (Norton et al., 2005; Kalea et al., 2005; Clark,
2007). According to Norton et al., wild blueberries incorporated into the diet
affected the vascular smooth muscle contractile machinery by suppressing the a1 adrenergic receptor-agonist-mediated contraction through an endotheliumdependent

pathway

(Norton

et al., 2005). Furthermore, wild

blueberry

consumption altered the structure of the extracellular matrix of Sprague Dawley
(SD) rat aortas, by increasing the concentration of glycosaminoglycans (GAGs)
and decreasing the sulfation of all GAG type molecules, suggesting a possible
effect of blueberries on endothelial and vascular smooth muscle signal
transduction pathways (Kalea et al., 2005). Results of a most recent study
documented that wild blueberries appeared to affect the endothelium-dependent
vasodilation of the aorta by modulating cell membrane-agonist interactions in
response to Ach in young normotensive SD rats and SHRs. Wild blueberries
affected the endothelial-dependent vasodilation in young SHR aorta most likely,
by modulating a key pathway of endothelial function, the cyclooxygenase (COX)
pathway (Clark 2007).
To our knowledge, the above studies are the only ones that investigate the
dietary effect of wild blueberries on endothelium-dependent vasodilation ex vivo.
Numerous studies have been conducted on other flavonoid-rich foods or isolated
compounds and have indicated the potential role of flavonoids in maintenance
and improvement of vasomotor tone. Short-term ingestion of purple grape juice
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improved flow mediated vasodilation and reduced LDL susceptibility to oxidation
in CAD patients (Stein et al., 1999). The beneficial effect of purple grape juice on
endothelium function was confirmed by another study in CAD patients (Chou et
al., 2001). Consumption of flavonol-rich dark chocolate decreased blood
pressure and improved endothelium-dependent relaxation in patients with
essential

hypertension. Furthermore,

insulin

resistance

and serum

LDL

cholesterol were reduced (Grassi et al., 2005). Moreover, short term intervention
with flavonoid-rich chocolate increased plasma epicatechin concentration and
improved endothelium-dependent vasodilation in healthy adults independent of
changes in oxidative stress and lipid profiles (Engler et al., 2004). When patients
with at least one cardiovascular risk factor were administered a single dose of
cocoa drink rich in flavan-3-ols, NO bioactivity was transiently increased over a 2
hour period. Endothelial vasodilation, measured by brachial flow mediated
dilation (FMD), was also increased (Heiss et al., 2003). Short and long-term
black tea consumption could reverse endothelial dysfunction in CAD patients as
reflected by increased flow-mediated dilation (Duffy et al., 2001). Similarly, in
healthy subjects endothelium-dependent vasodilation was significantly and
consistently increased by regular tea consumption (Hodgson et al., 2002). A
recent study suggested that the flavanol compound epicatechin, mediates, at
least in part, the beneficial vascular effects associated with the consumption of
flavanol-rich cocoa in humans, based on the finding that pure epicatechin
ingested by humans closely and quantitatively mimicked the vascular effects of
flavanol-rich cocoa (Schroeter et al., 2006).
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In SD rats, a diet rich in dealcoholated red wine, quercetin or catechin induced
endothelium dependent vasodilation via the NO-cGMP pathway (Benito et al.,
2002). Black currant concentrate, consisted of 10.83% anthocyanins, mostly
delphinidin and cyanidin, induced endothelium-dependent vasodilation and NO
release in SD rat aorta. It was suggested that the histamine receptor Hi may be
involved in the process (Nakamura et al., 2002). Extract of wine phenolics was
shown to reduce the elevation of blood pressure in Stroke-Prone Spontaneously
Hypertensive Rat (SHRSP), presumably through the observed increase in the
vasorelaxation activity (Mizutani et al., 1999). Incubation of femoral arterial rings
of Wistar Kyoto rats with red wine polyphenol powder, particularly rich in
proanthocyanidins, increased NO synthase activity and thereby, vasorelaxation
(Zenebe et al., 2003). Anthocyanin-enhanced extracts from chokeberry and
bilberry, but not elderberry produced dose-dependent vasorelaxation of porcine
coronary arteries. Even low concentrations of anthocyanins showed a significant
capacity to prevent loss of endothelium-dependent

vasodilation due to

exogenous ROS exposure (Bell and Gochenaur, 2006). The isolated flavonoids
baicalein, flavone and quercetin administered in SHRs for four weeks
significantly decreased endothelium-dependent vasodilation in response to Ach
(Machha et al., 2005). Acute exposure of the SHR aorta to quercetin (20 min
incubation with 10 umol/L) was shown to improve endothelium-dependent
relaxation and reduce the ai-adrenergic receptor-mediated contractile response
with potency greater than vitamin C (Ajay et al., 2006). Daily quercetin oral
administration (10 mg/kg) for five weeks reduced significantly systolic and
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diastolic blood pressure and elicited functional vascular changes in the SHR, but
not in the WK rat. Reduced cardiac and renal hypertrophy were also observed in
the SHR after the long term exposure to quercetin (Duarte et al., 2001). In
addition to lowering BP and heart rate of SHR, and enhancing endotheliumdependent vasodilation, quercetin enhanced eNOS activity and decreased
NADPH oxidase-mediated superoxide generation (Sanchez et al., 2006).
Delphinidin, but not malvidin or cyanidin, elicited

endothelium-dependent

vasodilation in WK rat aorta. The vasodilatory effect was completely mediated by
NO activity. The results indicated that, among anthocyanins, specific structures
are needed to modulate endothelium-dependent relaxation (Andriambeloson et
al., 1998). Red wine flavonoids were shown to up-regulate eNOS expression,
increase NO production in vitro, and therefore, improve endothelial dysfunction
(Diebolt et al., 2001). Wine, grape juice and grape skin extracts were shown to
produce endothelium-dependent relaxation in vitro, which was mediated by the
NO-cGMP pathway (Fitzpatrick et al., 1993). Several plant extracts also caused
endothelium-dependent vasodilation through an increase in cGMP levels
(Fitzptrick et al., 1995). Long term incubation of HUVECs with the crude extract
or organic subfraction of artichoke leafs, rich in flavonoids, increased eNOS
expression and NO production. Additionally ex vivo incubation of aortic rings with
the organic subfraction of artichoke leafs enhanced the NO mediated vasodilator
response to Ach (Li et al., 2004). Anthocyanin-rich berry extracts showed
considerable inhibitory effects on NO production from macrophages, and their
inhibitory effects were significantly correlated with the content of total phenolics,
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tartaric ester, flavonols, and anthocyanins (Wang and Mazza, 2002). The
flavonols

quercetin

and

myricetin,

and

the

anthocyanins/anthocyanidins

pelargonidin, cyanidin, delphinidin, peonidin, malvidin, malvidin 3-glucoside, and
malvidin 3,5-diglucosides, demonstrated >50% inhibition on NO production
without affecting cell viability (Wang and Mazza, 2002). Cyanidin and delphinidin
were both shown to significantly decrease ET-1 production and increase eNOS
activity in HUVECs. Delphinidin activity upon eNOS increase was dosedependent and greater in comparison with cyanidin (Lazze et al., 2006). The
superior vasoprotective effect of delphinidin was positively correlated with the
greater antioxidant activity due to the presence of three hydroxyl groups in the firing (Lazze et al., 2006). Cyanidin-3-glucoside induced eNOS expression and
NO release in bovine vascular endothelial cells (Xu et al., 2004a). The same
research team suggested that cyanidin-3-glycoside can regulate phosphorylation
of eNOS and the protein kinase Akt, which induces NO release via eNOS
activation. Cyandin-3-glucoside also affects the interaction of eNOS with sGC
increasing the cGMP production and subsequently inducing vasorelaxation (Xu
et al., 2004b). The inhibition of protein kinase C and cAMP release was proposed
by Duarte et al. (1993) as the main vasodilatory mechanism of flavonoids. The
potency of the flavonoids to induce vasorelaxation correlated with the potency to
inhibit protein kinase C. Inhibition of cyclic nucleotide phosphodiesterase or
decreased Ca2+ may also contribute to the vasodilatory effect. Additionally, the
structure seems to determine flavonoid activity with the flavonols quercetin,
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kaempherol and 5-O-methyl-quercetin being the most potent, followed by
flavones and lastly flavanols (Duarte etal., 1993).
The studies discussed above, suggest a great potential of flavonoids and
anthocyanins in particular, for improvement of endothelial function. However, the
exact molecular and biochemical mechanisms of action of these bioactive
substances remain to be elucidated. With regard to the cardiovascular health
effect of wild blueberries, human or animal studies are limited. Moreover, the
vast majority of the research conducted thus far, was aimed at studying the
polyphenols extracts of blueberries rather than the whole fruit added to the diet.
In addition, research on the blueberry extracts has been conducted mainly in
vitro (Bagchi et a/., 2004; Youdim et al., 2000; Youdim et a/., 2002).
In the present dietary study, the potential role of wild blueberries and their
possible mechanism of action on endothelium-dependent vasodilation in
response to Ach were investigated in SHR and normotensive WK rats in an ex
vivo experimental setting.
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CHAPTER 3
METHODS AND MATERIALS
3.1. Animal Models
Twenty male young adult Spontaneously Hypertensive rats (SHR) were used as
a model of endothelial dysfunction and 20 male young adult Wistar Kyoto rats
(WK) were used as a model of functional endothelium (controls). The Animal
Care and Use Committee of the University of Maine approved the animal care
and the experimental procedures.
Numerous pharmacological (Luscher and Vanhoutte, 1986; Xiao and Pang,
1994; Yang et al., 2002) and dietary studies (Duarte et al., 2001; Machha et al.,
2005; Rodriguez-lturbe et al., 2003) have utilized the SHR as a model of
endothelial

dysfunction. The normotensive

WK,

presenting

a functional

endothelium, is used as a control to the SHR, since SHR as a strain was
developed from outbred WK rats (Okamoto and Aoki, 1963).
Spontaneously

Hypertensive

rats

were

purchased

from

Charles

River

Laboratories (Wilmington, MA), while the WK rats were purchased from Taconic
Farm (Hudson, NY). All rats were purchased at the age of 12 weeks, placed on
dietary treatments for nine weeks and sacrificed at the age of 21 weeks.
The age of 10 weeks in the SHR is considered as the early hypertensive stage,
with a systolic BP at approximately 170 mmHg (Tenase et al., 1982).
Spontaneously hypertensive rats are expected to develop hypertension at the
age of 7 to 15 weeks and their systolic BP has been shown to plateau at
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approximately 200 mmHg (Yamori, 1984). Therefore, by 21 weeks of age SHRs
have developed full-blown hypertension.
The animals were housed in the Small Animal Facility at the University of Maine
in individual stainless-steel mesh-bottomed cages in an environmentally
controlled room maintained at 22°C with a 12:12-hour light: dark cycle. In order to
avoid possible infection, each strain was housed in separate rooms. All animals
were weighed weekly to determine possible differences in growth rate within
treatment groups. Also food consumption was measured daily to determine
possible differences in food intake among diet groups. Tap water and food was
provided ad libitum.
For the functional arterial property experiments, rats from each strain, SHR
and WK, were randomly assigned to one of two diets: control diet (C) and
blueberry diet (B) (control + 8% w/w wild blueberry powder substituting for
dextrose) for a period of nine weeks (Norton et al., 2005, Kalea et al., 2006, Clark
2006). Similarly, for the blood pressure measurement experiments, rats from
each strain, SHR and WK, were randomly assigned to one of the two diets: C
and B, as mentioned above, for a period of nine weeks. The C diet groups were
SHR-C and WK-C, n=10 each, and the B diet groups were SHR-B and WK-B,
n=10 each.

3.2. Animal Diet Composition
The animal diets were prepared in our lab, stored at 4°C and used within 5 to 7
days. The purified diet ingredients used were dextrose, egg white solids, vitamin
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mix, D,L-methionine, biotin, mineral mix, and corn oil (Table 3.1). The mineral
mix was purchased from ICN Biomedicals (Cleveland, OH), whereas all the other
ingredients were purchased from Harlan Teklad (Madison, Wl). For the
functional arterial property experiments, a wild blueberry composite was
provided by Wayman's (Cherryfiled, ME) and was freeze-dried with standard
procedures by Oregon Freeze Dry (Albany, OR). For the blood pressure
measurement experiments, the freeze-dried wild blueberry powder 1.5% N11
from Van Drunen Farms (Momence, IL) was utilized instead of the composite due
to lack of availability. The N11 wild blueberry powder from Van Drunen Farms is
standardized to contain a minimum 1.5% of total anthocyanins. For both
experiments, the wild blueberry powder was provided as 8% (w/w) of total diet
content, which is approximately equivalent to daily human consumption of a half
cup of fresh wild blueberries (Norton et al., 2005). The diet composition is
presented in Table 3.1.
Table 3.1. Diet Composition
Dietary Component

Control Diet (g)

Blueberry Diet (g)

Dextrose
Wild Blueberry
Egg white solids
Mineral mix (1 g/kg Mn)

691
0
200
35

611
80
200
35

Vitamin mix
Biotin
D-L-Methionine
Corn oil
(Total weight)

10
0.002
4
60
1000

10
0.002
4
60
1000
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3.3. Drugs and Solutions
The chemicals for the Physiologic Salt Solution (PSS), as well as the drugs used,
acetylcholine chloride (Ach), L-Phenylephrine (Phe), L-NG-monomethyl arginine
(L-NMMA), mefenamic acid (MFA) and pentobarbital sodium salt, were
purchased from Sigma Aldrich (St. Louis, MO). The heparin sodium injection
USP (1000 USP units/ml), was purchased from Baxter (Deerfiled, IL). The PSS
composition was the following: NaCI 118 mM, KCI 4.7 mM, CaCb 2.5 mM,
M g S 0 4 1 2 m M , KH2P04 1.2 mM, NaHC0 3 12.5 mM and dextrose 11.1 mM.

3.4. Aortic Ring Preparation
The use of animal arterial rings is an established experimental approach for
studying the role of the endothelium on arterial functional properties. Findings
from animal ring studies agree with those from isolated human vessels
(Vanhoutte, 1999).
Rats were anesthetized with 95%CC>2/ 5%02 for approximately 2 min. Blood
samples were collected via cardiac puncture. The thoracic aorta was excised and
placed in a silicon-coated petri dish, filled with PSS and cleaned from the
surrounding connective tissues and blood clots. The middle part of the aorta was
divided into four rings, each 3 mm of length, with surgical scissors (George
Tiemann & Co. Hauppauge, NY). The shape, length, or any damage of the aorta
during ring preparation were documented.
Each aortic ring was suspended by two stainless steel wire triangles and
mounted in a Radnoti tissue bath (Radnoti Glass Technology Inc. Monrovia, CA),
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containing PSS at 37°C and aerated with a gas mix of 95%0 2 / 5%C0 2 (pH 7.45).
The aortic rings were connected to Tissue Force Analyzers (TFA) (model 410,
Micro-Med Louisville, KY), that measured the force developed in the aorta in
response to the different drugs added in the tissue bath. The TFAs were
connected to a computer system that recorded via Digimed software, DMSI-210
(Micro-Med Louisville, KY) the force developed in the aorta, which as used to
estimate the experimental parameters, maximum force of vessel relaxation
(Fmax) and vessel reactivity (pD2). All rings from each animal were mounted in
the tissue baths within 60 min from the administration of anesthesia.

3.5. Experimental Design
3.5.1. Physiological Assessment of Arterial Functional Properties
Preliminary experiments were conducted to determine the Phe dose for the
maximal contraction of the aortic rings for each of the two strains by constructing
Phe dose-response curves. Following preconditioning of rings with Ach (10"8M)
and Phe (10"8M) for a period of 10 min, ten cumulative Phe doses were utilized
(10-9, 3x10"9, 10"8, 3x10~8, 10~7, 3x10-7, 10"6, 3x10-6, 10"5, 3x10-5M) for
constructing a Phe dose-response curve. A drug-tissue contact-time of six min
was allowed for each Phe dose to achieve maximum contraction. The Phe dose
that resulted in the maximal contraction of arterial rings was found in both strains
tobe10" 6 M.
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3.5.1.1. Vasodilation in the Absence of Inhibitors
Following a 45 min equilibration period under 1.5 g preload, rings were
preconditioned with Ach (10~8M) and Phe (10~8M) for a period of 10 min and then
washed out with PSS. The rings were then precontracted with one maximal dose
of the ai-adrenergic agonist Phe (10"6M). All the rings reached plateau of
maximal contraction within 10 min. Following the 10-min Phe precontraction,
eight concentrations of Ach (10-9, 3x10"9, 10'8, 3x10"8, 10'7, 3x10'7, 10'6, 3x10"6M)
were applied in order to construct the dose-response curve. A drug-tissue
contact-time of 6 min was allowed for each Ach concentration to achieve the
maximum relaxation to the initial precontraction (Figure 3.2).

3.5.1.2. Vasodilation in the Presence of Inhibitors
Inhibitors used were: L-NMMA (1(T*M) (NOS inhibitor) and MFA (10"5M) (nonselective COX inhibitor). Inhibitors were added after washing with PSS and were
allowed to stay in the tissue bath for 25 min before adding the Phe precontraction
dose (10"6M). Two separate Ach dose-response curves were generated. For the
first Ach dose-response curve, two of the rings were challenged with MFA (COXpathway inhibition), while no inhibitor was added in the other two aortic rings. For
the second Ach dose-response curve, L-NMMA only was added in two of the
rings (NOS-pathway inhibition), while both L-NMMA and MFA were added to the
other two aortic rings (COX and NOS-pathway inhibition). Thus, the effect of the
inhibitors on the NO and COX pathways was studied separately and
simultaneously (Figure 3.1, 3.2).
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=

igure 3.1. Vascular Ring Study Experimental Design

The digitized raw data were used to generate individual dose-response curves
and the following experimental parameters: maximal force of vessel relaxation
(Fmax), dose that inhibits 50% of vessel response (EC50) and vessel reactivity
(pD2). The force of relaxation at each Ach dose was determined as the percent
relaxation of the initial precontraction and used to construct dose-response
curves for each treatment. Among the values of vasorelaxation force at each of
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the eight Ach doses, the highest from each treatment group, was picked as the
Fmax. The EC50 values were obtained by transforming the dose response curve
to semi-log curves. Finally, the pD2 values were calculated as the - log EC50 in
order to give normally distributed data and used as an index of receptor agonist
interaction (Beach etal., 2001).
Table 3.2. Experimental Parameters
Biological
Assessment Method
Experimental
Interpretation
Parameter
Maximal force of vessel
Dose-response curve
Fmax
relaxation
Dose to inhibit 50% of
Transforming doseEC50
vessel response
response curves to semi
log curves
Vessel reactivity
Negative log EC50
pD2
(receptor-agonist
to give normally
interaction)
distributed data

3.5.2 Blood Pressure Measurement
After the nine week period of dietary treatment, rats were anesthetized with
sodium pentobarbital solution (60 mg/ml saline), (60mg/kg body weight)
intraperitoneally. A blunt dissection technique was used to dissect the neck area
of the animal, identify the carotid bundle and separate the left carotid artery from
nerve and muscle tissue (Whitesall et al., 2004). The left carotid artery was
cannulated with polyethylene tubing (PE-50) filled with heparinized saline (100
USP units/ 5 ml saline) and connected to a CyQ 103 pressure transducer
(Cybersense Inc. Nicholasville, KY) for the recording of systolic, diastolic and
mean arterial BP on a CyQ 302 recorder (Cybersense Inc. Nicholasville, KY).
Values for systolic, diastolic and mean arterial BP were recorded over a period of
30 min after connecting the animal to the transducer. After BP data were
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obtained, blood was collected through the cannula, centrifuged at 2500 rpm for
10 min and stored at - 80°C for further analysis.
3.6. Statistical Analysis
A Student t-test was used to determine the possible effect of diet on rat body
weights and food consumption between the diet groups within each strain (WK-B
vs. WK-C and SHR-B vs. SHR-C).
The Fmax and pD2 values in the absence or presence of inhibitors were
compared between treatment groups to determine the possible effect of diet.
Two-way Analysis of Variance (ANOVA) was used to compare equal number of
rank ordered observations for the Fmax and pD2 measurements. Two-way
ANOVA, was used to determine the possible effect of diet on systolic, diastolic
and mean BP between the diet groups within each strain (WK-B vs. WK-C and
SHR-B vs. SHR-C), as well as to determine the differences in blood pressure
between strains within each treatment group (WK-C vs. SHR-C and WK-B vs.
SHR-B).
The Sigmastat Statistical Program Package (SAS Institute Gary, NC) was used
to perform the statistical analysis. All values were given as mean ± SEM
(standard error of mean); differences were considered statistically significant at
p<0.05.
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CHAPTER 4
RESULTS
4 . 1 . Wistar Kyoto Rats
4.1.1. Rat Growth and Weight
Figure 4.1 represents the growth rate of WK rats fed control (WK-C) and wild
blueberry-enriched (WK-B) diet from 12 to 21 weeks of age. The rate of growth
during the nine week time-period was not significantly different between the two
diet groups. The final mean body weights at the end of the diet study were 576 ±
16.50 g and 552 ± 22.04 g for the WK-C and WK-B group respectively, which
were not significantly different, (p = 0.39). Additionally, no statistically significant
difference was found in the food intake of the two diet groups, 26 ± 0.63 g in the
WK-C group and 26 ± 0.63 g in the WK-B group, (p = 0.58).
Figure 4.1. Growth Rate of WK Rats (Weekly Weight*)
WK-C - . — WK-B

12

13

14

15

16

17

18

19

Age (weeks)

* Mean ± SEM (g)
WK-C: control group, (n = 10); WK-B: blueberry group, (n = 10)
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4.1.2. Effect of Diet on Maximum Vasodilation Force (Fmax)
The effect of diet on the Fmax in response to Ach a) in the absence of inhibitors
or in the presence of b) the COX-pathway inhibitor mefenamic acid (MFA) or c)
the NO-pathway inhibitor L-NG-monomethyl arginine (L-NMMA) or d) both
inhibitors added simultaneously is presented in Table 4.1 and Figure 4.2. No
significant difference was found between diet groups for any of the drug
treatments. The Fmax in response to Ach observed in the WK-B group (97.40 ±
1.78), was not significantly different from the Fmax observed in WK-C group
(97.92 ± 1.78), (p = 0.84). The Fmax observed in the WK-B group in the
presence of MFA (98.44 ± 1.20) tended to be higher than in the WK-C group
(95.60 ± 1.20), but the difference was not statistically significant, (p = 0.13). In the
WK-B group in the presence of L-NMMA (49.41 ± 1.91), Fmax was not
significantly different from the WK-C (50.36 ± 1.91) group, (p = 0.73). Similarly, in
the presence of both inhibitors Fmax was not significantly different between the
two diet groups (WK-B: 46.91 ± 1.84 vs. WK-C: 43.70 ± 1.84), (p = 0.25).
Table 4.1. Effect of Diet on the Fmax* in the Absence or Presence of
Inhibitors in the WK Rats
Diet group

Fmax Ach

WK-C
WK-B

97.92 ±1.78
97.40 ±1.78

Fmax Ach
MFA
95.60 ±1.20 b
98.44 ± 1.20

Fmax Ach
L-NMMA
50.36 ±1.91 b
49.41 ±1.91 b

Fmax Ach
MFA + L-NMMA
43.70 ±1.84 b
46.91 ±1.84 b

* Mean ± SEM
b Statistically significant compared to Ach treatment within the same diet group,
p<0.05 (n = 9)
No differences were detected among diet groups for any of the drug treatments.
WK-C: control group, (n = 9); WK-B: blueberry group, (n = 9); Ach: acetylcholine;
MFA: mefenamic acid; L-NMMA: L-NG-monomethyl arginine
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Figure 4.2. Effect of Diet on the Fmax* in the Absence or Presence of
Inhibitors in the WK Rats
a WK-C m WK-B I

-T—

TJ

70

o
to

SS

60

60 .;
40

MFA + L-NMMA

* Mean ± SEM
WK-C: control group, (n = 9); WK-B: blueberry group, (n = 9); Ach: acetylcholine;
MFA: mefenamic acid; L-NMMA: L-NG-monomethyl arginine
No differences were detected among diet groups for any of the drug treatments.

4.1.3. Effect of inhibitors on Maximum Vasodilation Force (Fmax)
Figure 4.3 presents the changes in the Fmax due to the addition of inhibitors
within the same diet group. The changes were calculated by subtracting the
Fmax in the presence of the inhibitors from the Fmax in the absence of inhibitors.
Inhibition of the COX pathway with MFA elicited a statistically significant
reduction of maximum vasodilation by 2% in the WK-C group, (p<0.05). In the
WK-B group, the maximum vasodilation was increased by 1% in the presence of
MFA, but this increase was not statistically significant, (p = 0.46). Inhibition of
NOS with L-NMMA reduced maximum vasodilation by 48% in both diet groups.
The difference in Fmax elicited by L-NMMA was statistically significant compared
with the Fmax in the absence of the inhibitor, (p<0.05).
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The presence of both inhibitors, MFA and L-NMMA, triggered a statistically
significant reduction in maximum vasodilation force by 54% in the WK-C group
and 51 % in the WK-B group, p<0.05.
Figure 4.3. Fmax* in the Absence or Presence of Inhibitors in the WK Rats
• Ach m MFA B LNMMA W MFA + L-NMMA

WK-C

WK-B

* Mean ± SEM
b
Statistically significant compared to Ach treatment, p<0.05 (n = 9)
WK-C: control group, (n = 9); WK-B: blueberry group, (n = 9); Ach: acetylcholine;
MFA: mefenamic acid; L-NMMA: L-NG-monomethyl arginine

4.1.4. Effect of Diet on Vasodilation Force, Ach Dose-Response Curves
Figures 4.4, 4.5, 4.6 and 4.7 display the dose-response curves of the Achinduced vasodilation in the aortic rings in the absence or presence of MFA, LNMMA or both MFA and L-NMMA. In the absence of inhibitors the vasodilation
force was not significantly different between the two diet groups (Figure 4.4). In
the presence of COX inhibitor MFA, the aortic rings of the WK-B group tended to
develop higher vasodilation than the WK-C group throughout the dose-response
curve, which was significant only for the 2nd, 3rd and 4 th Ach doses (3x1 fj 9 , 10"8
and 3x10"8M), (p<0.05) (Figure 4.5).
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Figure 4.4. Ach Dose-Response Curve in the Absence of Inhibitors in the
WK Rat Aorta
Ach

10"9

3x10"9

10-8

3x10"8
10-7
Ach dose (M)

3x10"7

10"6

3x10"6

WK-C: control group, (n = 9); WK-B: blueberry group (n = 9); Ach: acetylcholine
Figure 4.5. Ach Dose-Response Curve in the Presence of MFA in the WK
Rat Aorta
MFA

10*

3x10"9

1C)-8

3X10"8
10 7
Ach dose (M)

3x10"7

10-*

3X10-6

* Statistically significant compared to WK-C group, p<0.05
WK-C: control group, (n = 9); WK-B: blueberry group, (n = 9); Ach: acetylcholine;
MFA: mefenamic acid
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In the presence of NOS inhibitor L-NMMA, the aortic rings from the WK-B group
tended to develop lower vasodilation force throughout the dose-response curve,
which was significantly lower for the 3rd and 4 th Ach dose (10~8 and 3x10"8M),
(p<0.05) (Figure 4.6). When both inhibitors were added, the vasodilation force
was almost identical between the two diet groups for the first four Ach doses, but
the WK-B group exhibited significantly higher vasodilation force at the 5th and 6th
Ach dose (10~7 and 3x10"7M), (p<0.05) (Figure4.7).
Figure 4.6. Ach Dose-Response Curve in the Presence of L-NMMA in the
WK Rat Aorta
L-NMMA

10

3x10

10

3x10-8
10"7
Ach dose (M)

3x10-7

10-6

3x10"*

* Statistically significant compared to WK-C group, p<0.05
WK-C: control group, (n = 9); WK-B: blueberry group, (n = 9); Ach: acetylcholine;
L-NMMA: L-NG-monomethyl arginine
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Figure 4.7. Ach Dose-Response Curve in the Presence of both MFA and LNMMA in the WK Rat Aorta
MFA + L-NMMA

10-

3x10

10

3x10"8
10 7
Ach dose (M)

3x10"7

10"*

3x10*

* Statistically significant compared to WK-C group, p<0.05
WK-C: control group, (n = 9); WK-B: blueberry group, (n = 9); Ach: acetylcholine;
MFA: mefenamic acid; L-NMMA: L-NG-monomethyl arginine
4.1.5. Effect of Diet on Vessel Sensitivity (pD2)
The vessel sensitivity expressed as pD2 values for the aortic rings of WK rats fed
control and wild blueberry-enriched diet is displayed in Table 4.2 and Figure 4.8.
The pD2 in the absence of inhibitors was significantly lower in the WK-B group
(7.41 ± 0.02) than the WK-C group (7.49 ± 0.02), (p<0.05). The pD2 in the WK-B
group (7.51 ± 0.03) in the presence of MFA was not different than the pD2 of the
WK-C group (7.56 ± 0.03), (p = 0.21). The addition of L-NMMA did not elicit any
difference among diet groups, WK-B (6.81 ±0.10) and WK-C (6.65 ± 0.10), (p =
0.28). Similarly, the pD2 in the presence of both MFA and L-NMMA was not
different among diet groups, WK-B group (6.65 ±0.13) vs. WK-C group (6.56 ±
0.13), (p = 0.63).
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Table 4.2. Effect of Diet on the pD 2 * of WK Rat Aorta in the Absence or
Presence of Inhibitors
MFA
L-NMMA
Ach
Diet group
MFA + L-NMMA
7.49 ± 0.02
7.56 ± 0.03
6.65 ±0.10
6.56 ±0.13
WK-C
7.41 ± 0.02a
WK-B
* Mean ± SEM

7.51 ±0.03

6.81 ±0.10

6.65 ±0.13

a

Statistically significant compared to WK-C, p<0.05
WK-C: control group, (n = 9); WK-B: blueberry group, (n = 9); Ach: acetylcholine;
MFA: mefenamic acid; L-NMMA: L-NG-monomethyl arginine

Figure 4.8. Effect of Diet on the pD2* of WK Rat Aorta in the Absence or
Presence of Inhibitors
B WK-C

B WK-B

7.8

7.4
7.2

a

6.8

Q,

6.6
6.4
6.2 ...

5.8
Ach

MFA

L-NMMA

MFA + L-NMMA

* Mean ± SEM
Statistically significant compared to WK-C, p£0.05
WK-C: control group, (n = 9); WK-B: blueberry group (n = 9); Ach: acetylcholine;
MFA: mefenamic acid; L-NMMA: L-NG-monomethyl arginine
a

65

4.2. Spontaneously Hypertensive Rats
4.2.1. Rat Growth and Weight
Figure 4.9 represents the growth rate of SHRs fed control (SHR-C) and wild
blueberry-enriched (SHR-B) diet from 12 to 21 weeks of age. The rate of growth
during the nine week time period was not significantly different between the two
diet groups. The final mean body weights at the end of the diet study were 343 ±
2.70 g and 353 ± 5.34 g for the SHR-C and SHR-B group respectively, which
were not statistically significant, (p = 0.13). Also, no statistically significant
difference was found for food intake of the two diet groups, 20 ± 0.36 g in the
SHR-C group and 20 ± 0.36 g in the SHR-B group, (p = 0.45).
Figure 4.9. Growth Rate of SHRs (Weekly Weight*)

* Mean ± SEM (g)
SHR-C: control group, (n = 10); SHR-B: blueberry group, (n = 10)
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4.2.2. Effect of Diet on Maximum Vasodilation Force (Fmax)
The effect of diet on the Fmax in response to Ach a) in the absence of inhibitors
or in the presence of b) the COX-pathway inhibitor mefenamic acid (MFA) or c)
the NO-pathway inhibitor L-NG-monomethyl arginine (L-NMMA) or d) both
inhibitors added simultaneously, is presented in Table 4.3 and Figure 4.10. The
Fmax in response to Ach observed in the SHR-B group (92.13 ± 0.56) was
significantly lower than the Fmax observed in the SHR-C group (94.63 ± 0.56),
(p<0.05), while the Fmax observed for the SHR-B group (102.17 ± 0.57) in the
presence of MFA was significantly higher than in the SHR-C group ((97.76 ±
0.57), (p<0.05). In presence of L-NMMA, Fmax, did not differ significantly among
diet groups (SHR-B group: 46.45 ± 0.49 vs. SHR-C group: 45.36 ± 0.49), (p =
0.16). Finally, when both inhibitors were present, Fmax was similar in the two diet
groups (SHR-B group: 53.60 ± 0.89 vs. SHR-C group: 53.49 ± 0.89), (p = 0.93).
Table 4.3. Effect of Diet on the Fmax* in the Absence or Presence of
Inhibitors in the SHRs
Diet group

Fmax Ach

Fmax Ach
MFA

Fmax Ach
L-NMMA

Fmax Ach
MFA + L-NMMA

SHR-C

94.63 ± 0.56

97.76 ± 0.57b

45.39 ± 0.49b

53.49 ± 0.89b

102.17 ±0.57 a b

46.45 ± 0.49b

53.60 ± 0.89b

92.13 ±0.56 a
SHR-B
* Mean ± SE M

a

Statistically significant compared to SHR-C group, p<0.05
Statistically significant compared to Ach without the presence of inhibitors within
the same diet group, p^0.05 (n = 10)
SHR-C: control group, (n = 10); SHR-B: blueberry group, (n = 10); Ach:
acetylcholine; MFA: mefenamic acid; L-NMMA: L-NG-monomethyl arginine
b
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Figure 4.10. Effect of Diet on the Fmax* in the Absence or Presence of
Inhibitors in the SHRs

* Mean ± SEM
Statistically significant compared to SHR-C, p<0.05
SHR-C: control group, (n = 10); SHR-B: blueberry group, (n = 10); Ach:
acetylcholine; MFA: mefenamicacid; L-NMMA: L-NG-monomethyl arginine

a

4.2.3. Effect of Inhibitors on Maximum Vasodilation Force (Fmax)
Figure 4.11 presents the changes in the Fmax due to the addition of inhibitors
within the same diet group. The changes were calculated by subtracting the
Fmax in the presence of the inhibitors from the Fmax in the absence of inhibitors.
Inhibition of the COX pathway with MFA resulted in a significant increase of
maximum vasodilation by 3% in the SHR-C group, while in the SHR-B group, the
presence of MFA triggered a 10% increase in the Fmax, (p<0.05). Inhibition of
the NOS with L-NMMA reduced maximum vasodilation by 49% in the SHR-C
group and by 46% in the SHR-B group. The change in Fmax induced by LNMMA was statistically significant in both diet groups, (p<0.05). The presence of
both inhibitors, MFA and L-NMMA, caused a significant reduction in maximum
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vasodilation force by 4 1 % in the SHR-C group and 39% in the SHR-B group,
(p<0.05).
Figure 4.11. Fmax* in the Absence or Presence of Inhibitors in the SHRs
• Ach a MFA P L-NMMA ® MFA + L-NMMA
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* Mean ± SEM
Statistically significant compared to SHR-C, p<0.05
b
Statistically significant compared to Ach treatment, p<0.05 (n = 10)
SHR-C: control group, (n = 10); SHR-B: blueberry group, (n = 10); Ach:
acetylcholine; MFA: mefenamic acid; L-NMMA: L-NG-monomethyl arginine
a

4.2.4. Effect of Diet on Vasodilation Force, Ach Dose-Response Curves
Figures 4.12, 4.13, 4.14 and 4.15 display the dose-response curves of the Achinduced vasodilation in the aortic rings in the absence or presence of MFA, LNMMA or both MFA and L-NMMA. In the absence of inhibitors, the vasodilation
force was significantly greater in the SHR-B group for the 2 nd and 3rd Ach dose
(3x10"9 and 10"8M), but significantly lower for the 4 th , 5th and 6th Ach dose (10 7 ,
3x10"7 and 3x10"6M), (p<0.05) (Figure 4.12).
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Figure 4.12. Ach Dose-Response Curve in the Absence of Inhibitors in the
SHR Aorta
Ach
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* Statistically significant compared to SHR-C, p<0.05
SHR-C: control group, (n = 10); SHR-B: blueberry group, (n = 10); Ach:
acetylcholine

In the presence of COX inhibitor MFA, the aortic rings from the SHR-B developed
significantly greater vasodilation for all Ach doses (p<0.05) (Figure 4.13), while in
the presence of NOS inhibitor L-NMMA, the aortic rings from the SHR-B group
developed significantly greater vasodilation at the 3rd, 4 th and 7th Ach doses only
(10~8, 3x10"8 and lO^M), (p<0.05) (Figure 4.14). When both inhibitors were
added, the SHR-B aortic rings exhibited significantly higher vasodilation
response than the SHR-C rings, at the first four Ach doses (10"9, 3x10"9, 10~8 and
3x10"8M), (p<0.05) (Figure 4.15).

70

Figure 4.13. Ach Dose-Response Curve in the Presence of MFA in the SHR
Aorta
MFA
-SHR-B
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Ach dose (M)

* Statistically significant compared to SHR-C group, p<0.05
SHR-C: control group, (n = 10); SHR-B: blueberry group, (n = 10); Ach:
acetylcholine; MFA: mefenamic acid
Figure 4.14. Ach Dose-Response Curve in the Presence of L-NMMA in the
SHR Aorta
L-NMMA
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* Statistically significant compared to SHR-C group, p<0.05
SHR-C: control group, (n = 10); SHR-B: blueberry group, (n = 10); Ach:
acetylcholine; L-NMMA: L-NG-monomethyl arginine
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Figure 4.15. Ach Dose-Response Curve in the Presence of both MFA and LNMMA in SHR Aorta
MFA + L-NMMA
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* Statistically significant compared to control group, p<0.05
SHR-C: control group, (n = 10); SHR-B: blueberry group, (n = 10); Ach:
acetylcholine; MFA: mefenamic acid; L-NMMA: L-NG-monomethyl arginine

4.2.5. Effect of Diet on Vessel Sensitivity (pD2)
The vessel sensitivity expressed as pD2 values for the aortic rings of SHRs fed
control and wild blueberry-enriched diet is displayed in Table 4.4 and Figure
4.16. The pD2 in the absence of inhibitors did not differ among diet groups (SHRB group: 7.54 ± 0.02 vs. SHR-C group: 7.59 ± 0.02), (p = 0.11). In the presence
of MFA the pD2 in the SHR-B group (7.72 ± 0.02) was significantly greater than
the SHR-C group (7.63 ± 0.02), (p<0.05). The pD2 was also found to differ
significantly among diet groups in the presence of L-NMMA, SHR-B: 7.17 ± 0.02
vs. SHR-C: 7.04 ± 0.02, (p<0.05). Finally, the pD2 in the presence of both MFA
and L-NMMA was not different between diet groups (SHR-B: 7.20 ± 0.04 and
SHR-C: 7.25 ± 0.04), (p = 0.38).
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Table 4.4. Effect of Diet on the pD2* of SHR Aorta in the Absence or
Presence of Inhibitors
Diet group
SHR-C

Ach
7.59 ± 0.02

MFA
7.63 ±0.02

LNMMA
7.04 ± 0.02

MFA + L-NMMA
7.25 ± 0.04

SHR-B

7.54 ±0.02

7.72 ± 0.02a

7.17±0.02 a

7.20 ± 0.04

*Mean±SEM
a
Statistically significant compared to SHR-C, p<0.05
SHR-C: control group, (n = 10); SHR-B: blueberry group, (n = 10); Ach:
acetylcholine; MFA: mefenamic acid; L-NMMA: L-NG-monomethyl arginine

Figure 4.16. Effect of Diet on the pD2* of SHR Aorta in the Absence or
Presence of Inhibitors
S3 SHR-C M SHR-B
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* Mean ± SEM
Statistically significant compared to SHR-C, p<0.05
SHR-C: control group, (n = 10); SHR-B: blueberry group, (n = 10); Ach:
acetylcholine; MFA: mefenamic acid; L-NMMA: L-NG-monomethyl arginine

a
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4.3. Blood pressure (BP)
Blood pressure was measured in WK rats and SHRs fed a control or wild
blueberry-enriched diet for nine weeks. Measurements of systolic, diastolic and
mean arterial BP were taken. Even though systolic, diastolic and mean BP was
significantly different between rat strains (p<0.05), no significant difference was
detected between dietary treatments (Figure 4.17, 4.18). Table 4.5 presents the
mean systolic, diastolic and mean arterial BP in the WK rats. The mean systolic
BP in the WK-B group (136 ± 1.55 mmHg) was not significantly different from the
WK-C group (133 ± 1.55 mmHg), (p = 0.29). Similarly, the mean diastolic BP in
the WK-B group (100 ± 1.95 mmHg) did not differ significantly from the WK-C
group (94 ± 1.95 mmHg), (p = 0.52). Finally, no significant difference was
observed in the mean arterial BP in the WK-B group (117 ± 1.78 mmHg) vs. the
WK-C group (112 ± 1.78 mmHg), (p = 0.08). Table 4.6 presents the mean
systolic, diastolic and mean arterial BP in the SHRs. No significant differences
were detected between diet groups in the mean systolic BP (SHR-B group: 224 ±
3.66 mmHg vs. SHR-C group: 221 ± 3.66 mmHg, p =0.56), the mean diastolic BP
(SHR-B group: 151 ± 1.43 mmHg vs. SHR-C group: 150 ± 1.43 mmHg, p = 0.52)
and the mean arterial BP (SHR-B group: 183 ± 2.10 mmHg vs. SHR-C group:
180 ±2.09 mmHg, p = 0.47).
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Figure 4.17. Systolic, Diastolic and Mean Arterial BP1 in WK-C and SHR-C
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* Statistically significant compared to WK-C, p < 0.05
WK-C: control group (n = 10); SHR-C: control group (n = 10)
Figure 4.18. Systolic, Diastolic and Mean Arterial BP1 in WK-B and SHR-B
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WK-B: blueberry group (n = 10); SHR-B: blueberry group (n = 10)
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Mean

Table 4. 5. Effect of Diet on the Systolic, Diastolic and Mean Arterial BP1 in
the WK Rats
Diet group
WK-C
WK-B

Systolic BP
133 ±1.55
136 ±1.55

Diastolic BP
94 ±1.95
100 ±1.95

Mean BP
112 ±1.77
117 ± 1.77

1

Mean ± SEM (mmHg)
WK-C: control group, (n = 10); WK-B: blueberry group, (n = 10); BP: blood
pressure
No significant differences were detected among WK-C and WK-B.
Table 4.6. Effect of Diet on the Systolic, Diastolic and Mean Arterial BP1 in
the SHRs
Diet group
SHR-C
SHR-B

Systolic BP
221 ± 3.66
224 ± 3.66

Diastolic BP
150 ±1.43
151 ±1.43

1

Mean BP
180 ±2.09
183 ±2.09

Mean ± SEM (mmHg)
SHR-C: control group, (n=10); SHR-B: blueberry group (n = 10); BP: blood
pressure
No significant differences were detected among SHR-C and SHR-B.
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CHAPTER 5
DISCUSSION
5.1. Summary of Results
The aim of the present study was to evaluate the ex vivo effect of nine week
dietary treatment with wild blueberries (Vaccinum angustifolium) on the arterial
functional properties of the hypertensive and normotensive young adult rat. Wild
blueberries were provided at 8% (w/w) of total diet content, which is equivalent to
daily human consumption of a half cup of fresh-wild blueberries (Norton ef a/.,
2005). To our knowledge there are no feeding studies on the effect of wild
blueberries on vasomotion besides the studies conducted in this laboratory
(Kalea etal., 2005; Norton et al., 2005; Clark, 2007). Previous studies conducted
in our laboratory reported that wild blueberries can reduce vasoconstriction
induced by phenylephrine (Phe) in the aorta of young normotensive young
Sprague-Dawley (SD) rats, an action that requires an intact and functional
endothelium. In SD rats of this age, wild blueberries do not seem to exert their
effect on vasoconstriction in response to Phe through cell membrane receptoragonist interactions (Norton et al., 2005). Additionally, wild blueberries were
shown to affect the endothelium dependent-vasodilation via the NO pathway in
young normotensive SD and by modulating the production and/or the activity of
COX-derived products in the young hypertensive SHR aorta (Clark, 2007). The
same study confirmed that in the normotensive SD rat, the endotheliumdependent vasodilation

is primarily

mediated
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by NO. Additionally, wild

blueberries exert their effect on acetylcholine (Ach)-induced vasodilation by
modulating cell membrane receptor-agonist interactions (Clark, 2007).
The objectives of the current study were to examine the possible effect of wild
blueberries on endothelium-dependent vasodilation in aortas with dysfunctional
endothelium from young adult SHRs with full-blown hypertension, and their
controls, the normotensive WK rats with functional endothelium, in an attempt to
dissect the biochemical mechanism that wild blueberries may employ on
vasodilation in the young adult hypertensive rat and normotensive rat.
We documented that in the young adult normotensive WK, wild blueberries do
not affect maximum endothelium-dependent vasodilation in response to Ach.
However, wild blueberries seem to modulate the cell membrane receptor-agonist
interactions in response to Ach in the above strain. In the young adult SHR, wild
blueberries reduce the maximum vasodilation force in response to Ach, an effect
which is mediated by the COX pathway, as shown by the increased maximum
vasodilation force in response to Ach with the COX-pathway inhibition.
Furthermore, the SHR-B aortic rings exhibited greater Ach-induced vasodilation
at lower Ach doses (3x10"9 and 10"8M) compared to SHR-C. Additionally, wild
blueberries seem to have an effect on the receptor-agonist interactions in
response to Ach in the young adult SHR when either NO or COX pathway is
inhibited. Finally, wild blueberries did not have a significant effect on the systolic,
diastolic and mean arterial blood pressure (BP) in either strain of rats. Hence, the
effect of wild blueberries on vasodilation may be strain-dependent and/ or
depend on the physiological state of the aorta (functional vs. dysfunctional
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endothelium) as shown by the differential effect upon the functional endothelium
of WK and dysfunctional endothelium of SHR. Additionally, the effect of wild
blueberries on vasodilation does not seem to be associated with regulation of BP
in the young adult SHR and WK rat.

5.2. Wistar Kyoto Rats
5.2.1. Effect of Wild blueberries on Endothelium-Dependent Vasodilation in
Response to Ach
In the present study, the Ach-induced vasodilation in the aortas between diet
groups was similar in the young adult WK rats. In agreement with these findings
a recent study conducted in our laboratory on young SD rats did not reveal any
significant effect of wild blueberry-enriched diet on Ach-induced vasodilation
(Clark, 2007). It can be therefore suggested that wild blueberries do not seem to
influence the muscarinic receptor in smooth muscle cells. However, wild
blueberry diets affect the arterial biomechanical properties by suppressing the CHadrenergic receptor-agonist vasoconstriction induced by Phe, as documented by
an earlier dietary study on young normotensive SD rats conducted in our
laboratory (Norton et a/., 2005). Thus, wild blueberries have differential effects on
different receptors of vascular cells.
The involvement of NO and COX pathways in endothelium-mediated vasodilation
in response to Ach was evaluated by their inhibition with L-NMMA and MFA
respectively. Additionally, both inhibitors were used simultaneously to examine
the potential role of NO-COX interaction on vasodilation. The presence of any of
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the inhibitors, either separately or simultaneously, did not have any significant
effect on the vasodilation between the two diet groups. These findings suggest
that wild blueberries do not affect to a great extend the NO or COX-mediated
pathways in the young adult normotensive WK when provided at 8% of total diet
composition and for the period of nine weeks. The inhibitory effect of L-NMMA on
vasodilation was more pronounced in young SD rats fed wild blueberries versus
SD rats fed a control diet (Clark, 2007), implying that wild blueberries show
potential in enhancing or preserving NO bioavailability in animals with functional
endothelium. However, in the present study, utilizing a different strain of
normotensive rat, the WK, did not seem to affect the vasodilation pathways
studied.
It is not clear why wild blueberries seem to be involved in the NO pathway in the
SD but not in the WK rats, since both strains have a functional endothelium.
Interspecies variability in the type, density and conformation of agonist receptors,
as well as in the structure of the vascular wall itself, may explain the above
observations. Additionally, the age difference, i.e. young SD vs. young adult WK,
may also contribute to the above phenomenon. A study by Vizioli et al. (2005),
indicated that vasodilation of the thoracic aorta of 12 to 14 week-old WK rats in
response to Ach, besides NO, involves COX-derived prostanoids as indicated by
inhibition with indomethacin (Vizioli et al., 2005). Another study by Heymes et al.
(2000), documented that in old WK rats (24 vs. 4 months of age) vasoconstrictor
prostanoids may reduce Ach-induced vasodilation (Heymes et al., 2000). Hence,
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it is possible that in the WK rats the action of prostanoids may shift from
vasodilatory in younger age to vasoconstrictor in older aged rats.
Rapoport and Williams (1996) proposed prostacyclin (PGI2) as the endotheliumderived contracting factor responsible for Ach induced contractions in 7 to12
months-old WK rats (Rapoport and Williams, 1996). Moreover, in the aorta of WK
rat older than 15 weeks, PGb receptor (IP) agonist cannot evoke IP receptormediated relaxations (Levy, 1980; Rapoport and Williams, 1996).
In the present study, the maximum vasodilation was not different between diet
groups after COX pathway inhibition in the WK rat. Similarly, wild blueberries did
not have a significant effect on maximum vasodilation under the COX inhibition in
the SD rat (Clark, 2007). The inhibition of the COX pathway significantly reduced
vasodilation in the WK-C group, possibly by preventing the generation of COXderived vasoconstrictors. However, COX-inhibition did not alter significantly the
maximum vasodilation in the WK-B group, suggesting that wild blueberries may
cancel out the vasoconstrictor effect of COX through an unknown as yet
mechanism.
The inhibition of NO pathway did not elicit a different response in the maximum
vasodilation force between diet groups in the young adult WK rat. However, the
possibility that wild blueberries may protect NO bioavailability in the WK rat,
cannot be excluded in the view of previous findings that wild blueberry exhibited
the potential to preserve NO in the SD rat (Clark, 2007).
The vasorelaxant and the NO-protective effect of isolated flavonoid compounds
in normotensive animal models with functional endothelium, has been
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demonstrated by several studies (Andriambeloson et al., 1998; Zenebe et a/.,
2003; Benito era/., 2002; Chung et al., 1993; Nakamura et al., 2002). Delphinidin
was shown to elicit an endothelium-dependent vasodiiatory effect in WK rat
aorta, which was completely mediated by NO activity (Andriambeloson et al.,
1998). Additionally, incubation of WK femoral artery with red wine polyphenol
powder, particularly rich in proanthocyanidins, increased NO bioactivity and
vasorelaxation (Zenebe et al., 2003). Quercetin and structurally

related

compounds showed vasorelaxant activity in the thoracic WK rat aorta by
suppressing the Ca2+- and Phe-induced contractions (Chung et al., 1993). In SD
rats, black currant concentrate, rich in delphinidin and cyanidin (Nakamura et al.,
2002) as well as a diet rich in dealcoholated red wine, quercetin or catechin
(Benito et al., 2002), elicited a vasodiiatory effect mediated by the NO pathway.
Similarly, incubation of SD rat aortic rings with the flavonoid-rich artichoke leaf
organic subtraction was shown to enhance the NO mediated vasodilator
response to Ach (Li et al., 2004).
Our observations from the inhibition of the NO and COX pathway are in
agreement with the work of Vizioli et al. (2005), which showed that in the thoracic
aorta of 12 to 14 week-old WK, the Ach-induced vasodilation was inhibited by LNMMA treatment and was partially reduced by the non-selective COX-inhibitor
indomethacin. Additionally,

treatment

of

rings with

both

L-NMMA

and

indomethacin also reduced the vasodilation response to Ach (Vizioli et al., 2005).
The only difference is that in our study, the inhibition of the COX-pathway in the
WK fed wild blueberry, did not significantly alter the Ach-induce vasodilation
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force. Vassale et al. (2003) indicated that a pronounced release of NO is
expected when COX is inhibited in order to compensate for the reduced PGI2
levels, whereas the vasodilator prostaglandins seem to have no capacity to
modulate NO release in the endothelial cells when NO synthase is inhibited
(Vassale et al., 2003). This finding further supports the role of wild blueberries on
preserving NO, since wild blueberry treatment may potentiate a greater NO
bioavailability, in comparison to the control. Fundamentally, in both human
subjects and animal models with functional endothelium, NO is the primary
mediator of the Ach-induced vasodilation (Taddei and Salvetti, 2002). Our study
confirmed that inhibition of NO synthase by L-NMMA leads to a far greater
attenuation of vasodilation force than the inhibition of COX.
Overall, although the wild blueberry treatment did not elicit any significant change
in the vasodilation force in the normotensive WK rat aorta, the possibility that it
may act on preserving the NO bioavailability in the WK rat, cannot be excluded.

5.2.2. Vessel Reactivity
Vessel reactivity or sensitivity, pD2, is an index of cell membrane-receptor
agonist interactions. Vessel reactivity is the negative log of the concentration of
the agonist required to inhibit 50% of the vessel response, EC50. In our study,
PD2 is used as an indication of whether wild blueberries can affect the cell
membrane-receptor agonist interactions. In the WK rat, Ach induced a significant
difference on the pD2 values among the two diet groups. The WK-B group
showed a decrease in the vessel sensitivity as compared to the control. This
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finding suggests a possible interaction between membrane receptors and the
muscarinic agonist Ach in the WK-B group. Our observations on vessel
sensitivity on the WK rat agree with Clark (2007), who also reported an effect of
wild blueberries on the vessel sensitivity of the SD rats (Clark, 2007).
Previous work in Dr. Klimis-Zacas' laboratory reported that blueberries can
modulate the structure of the extracellular matrix (EC) of young male SD rat
aortas by increasing the concentration of glycosaminoglycans (GAGs) and
decreasing the sulfation of all GAG-type molecules (Kalea et a/., 2005).
Glycosaminoglycans are structural components of the glycocalyx, which coats
the luminal surface of the vascular endothelial cells. The glycocalyx is considered
a first line of protection against atherogenic damage of the endothelium (van den
Berg et a/., 2006). Glycosaminoglycans participate in the structural organization
of the EC and in the regulation of several vascular functions. A possible role in
signal transduction pathways has been attributed to the effect of GAG sulfation,
in Ach-receptor clustering and therefore sensitivity (Mc. Donnell and Grow,
2000). Furthermore, several enzymes such as eNOS, superoxide dismutase
(SOD) or angiotensin converting enzyme (ACE), growth factors and chemokines,
all with a principal role in plasma and vessel wall homeostasis are present in the
vascular environment. Therefore the glycocalyx is a vital player of endothelial
function and homeostasis (van den Berg et al., 2006). Based on the findings that
wild blueberries were shown to alter the structure of the EC, a possible effect of
blueberries on endothelial and vascular smooth muscle signal transduction
pathways in the WK rat can be implied.
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5.3. Spontaneously Hypertensive Rats
5.3.1. Effect of Wild Blueberries on Endothelium-Dependent Vasodilation in
Response to Ach
This study was aimed at clarifying the possible effect of wild blueberries on
endothelium-dependent vasodilation in the aorta of young adult SHR with a
dysfunctional endothelium. The SHRs develop hypertension without exception
between the age of 7 to 15 weeks (Yamori, 1984). The present study on arterial
functional properties was conducted on 21 week-old SHRs after 9 weeks of
dietary treatment in order to investigate the role of wild blueberries in fullydeveloped hypertension.
Acetylcholine dose-response curves in the absence and in the presence of NO
and COX inhibitors were constructed to study the effect of wild blueberries on
vasodilation pathways in the SHR aorta. In the absence of inhibitors, the doseresponse curve revealed that the vasodilation force was higher in the SHR-B
group at the lower Ach doses but lower at the higher Ach doses (Figure 4.12).
Overall, a significantly lower vasodilation force in response to Ach in the SHR-B
group versus the SHR-C group was observed. Hence, wild blueberries act to
increase the vasodilatory response to Ach at lower doses, whereas this effect is
reversed at the higher Ach doses. In the SHR, higher Ach doses than those
required for vasodilation, can induce vasoconstriction due to EDCF release, but
also due to a direct effect on VSMC (Boulanger et al., 1994; Luscher and
Vanhoutte, 1986). However, in the young SHR wild blueberries did not alter the
endothelium-dependent vasodilation in response to Ach in the absence of
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inhibitors. The same study indicated that the vasodilation force developed in the
young SHR fed wild blueberry was higher at the Ach doses 10~8 and 3x10"8M but
not different at any other Ach dose (Clark, 2007). Hence, the vasodilatory effect
of wild blueberries at lower Ach doses in young and young adult SHR is similar.
However, at higher Ach doses, the wild blueberry diet seems to have a different
and probably age-dependent effect on vasodilation.
In SHRs younger than 14 weeks old, the endothelium-mediated vasorelaxation
seems to be similar to normotensive rats of the same age and therefore young
SHRs may be considered as normotensive before full development of
hypertension (Cappelli-Bigazzi et ai, 1997). Acetylcholine-mediated vascular
relaxation, even after treatment with the COX inhibitor indomethacin, did not
differ significantly among normotensive and young SHR, while the release of
COX-dependent vasoconstrictors occurred only in vessels of aged normotensive
or SHR animals and in response to higher concentrations of Ach (10~5 and 10"6M)
(Koga et ai, 1989). Hence, it is possible that a greater release of COX-derived
vasoconstrictors occurs at higher Ach doses in the young adult SHR vs. the
young SHR, which can mask any possible effect of wild blueberries on
vasodilation. Cyclooxygenase-derived vasoconstrictors generated in response to
higher Ach doses may be responsible for the observed decline in the wild
blueberry effect on vasodilation occurring in higher Ach doses (3x10"8 to 3x10"
6

M). It has been reported that in the 12 to 14 week-old SHR, endoperoxides

(PGH2) account for the reduced endothelium dependent contraction, whereas in
the 72 week-old rat impaired NO formation and/ or increased NO inactivation
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seem to be involved as well (Kung and Luscher, 1995). Furthermore, in one year
old SHR, PGI2 induced by Ach was shown to act as a contracting and not a
relaxing factor (Gluais et al., 2005), probably due to a decreased response of the
IP receptor. In the aorta of older than 15 weeks WK or SHR, IP receptor agonists
cannot evoke relaxations (Levy, 1980; Rapoport and Williams, 1996). The
expression of the IP receptor gene decreases with age in the SHR and WK rat as
well (Numaguchi et al., 1999). Hence the aging process, by favoring a
vasoconstrictor state in the aorta, may contribute to the decreased vasodilation
observed in the young adult SHR fed wild blueberry, possibly due to the
interaction of wild blueberry with one or more factors that induce age-dependent
changes such as prostaglandins or their receptors. Furthermore, it can be
suggested that the greater vasodilation observed at the lower Ach doses in the
SHR may reflect a potential effect of blueberries on initial precontraction rather
than an effect on vasodilation. As observed by Norton et al. (2005), wild
blueberries were shown to suppress the ai-adrenergic

receptor-agonist

vasoconstriction induced by Phe in the SD rat (Norton et al, 2005). This
possibility cannot be ignored, even though the effect of wild blueberries may be
different among strains. Studies on the effect of wild blueberries on the
vasoconstriction in the SHR are not currently available to clarify this possibility.
The inhibition of the COX pathway produced higher vasodilation in the SHR-B
aorta versus the SHR-C, suggesting a possible effect of wild blueberries on the
COX-derived vasodilatory prostanoids in the young adult SHR. On the other
hand, the inhibition of NO synthesis with L-NMMA did not induce any difference
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in the vasodilation among the diet groups, implying that wild blueberries do not
affect NO bioavailability in the young adult SHR aorta. Wild blueberries have
been shown to preserve NO bioavailability in the young normotensive SD rats
(Clark, 2007). However, the endothelial dysfunction in the SHR seems to limit the
wild blueberry potential in preserving NO bioavailability. In the SHR the
endothelium-dependent vasodilation seems to be impaired due to a reduced
availability of NO (Kerr et al., 1999; Xiao and Pang, 1994). Besides the reduced
NO release, the increased release of EDCF(s) also accounts for the blunted
endothelium-dependent relaxations to Ach in the SHR aorta (Luscher and
Vanhoutte, 1986).
In our study, when the release of the COX-derived vasodilators such as PGb and
vasoconstrictors such as TXA2, was inhibited by MFA, wild blueberries exhibited
a vasorelaxant effect. An enhanced release of NO may occur with the inhibition
of PGI2 generation (Vassale et al., 2003). Wild blueberries may further aid this
compensatory mechanism by preserving NO bioavailability due to their
antioxidant properties (Mazza et al., 2002; Kay and Holub, 2002). In the present
study, when vascular rings were treated with MFA, the vasodilation force was
increased in both diet groups, confirming the finding by Taddei et al. (1998) that
COX inhibition can increase or normalize the blunted Ach-induced vasodilation of
dysfunctional endothelium (Taddei et al., 1998). When both NO and COX
pathways were inhibited, vasodilation was decreased in both diet groups, but
there was no difference in the vasodilatory response between them. The NO and
COX pathways constantly interact and therefore manipulation of one pathway

88

may have an effect on both (Mollace et al., 2005). As previously mentioned, in
our study, when both NO and COX pathways were operating, the vasodilation
force was decreased in the SHR-B group, but it cannot be determined whether
this effect is due to a direct influence of wild bueberries on COX derived
vasoconstrictors, or to an indirect adverse effect of COX-derived vasoconstrictors
on NO bioavailability.
Cyclooxygenase is overexpressed in the SHR, resulting in an increased
production of vasoconstrictor prostanoids (Vanhoutte et al., 2005), as well as an
increased ROS levels (Katusic, 1996). The excessive production of superoxide
anion results in the increased oxidative stress in the vascular walls of SHR,
which has been postulated to mediate endothelial dysfunction (Kerr et al., 1999;
Yang et al., 2002; Cuzocrea et al., 2004). Antioxidant dietary treatment has been
shown to improve the endothelial function in the SHR (Maccha and Mustafa,
2005). The endothelium-dependent vasodilator response to Ach and overall
endothelial function can be restored in SHR treated with y-tocotrienol (Newaz et
al., 2003) or in hypertensive humans treated with vitamin C (Taddei et al., 1998),
as a result of the antioxidant and free radical scavenging activity of the vitamins.
Besides antioxidant vitamins, several flavonoid compounds have demonstrated a
protective activity against oxidative stress. The antioxidant activity of cyanidin-3
galactoside and several quercetin glycosides isolated from cranberry was
comparable to vitamin E (Yan et al., 2002). By scavenging peroxynitrite (ONOO")
cyanidin-3-O-glucoside from blackberry juice had a protective in vitro effect
against endothelial dysfunction and vascular failure (Serraino et al., 2003). Red
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wine polyphenols, delphinidin and cyanidin can directly scavenge ROS and
prevent the ROS platelet derived growth factorAB (PDGFAB)-induced formation in
cultured vascular smooth muscle cell (VSMC). Additionally malvidin and peonidin
although they did not scavenge ROS, prevented their cellular formation (Oak et
al., 2006).
Wild blueberries have been endowed with antioxidant properties (Mazza et al.,
2002; Kay and Holub, 2002); therefore they may protect endothelium function
through ROS scavenging. Besides free radical scavenging, wild blueberry
components can modulate other mechanisms towards a vasoprotective result.
The inhibition of protein kinase C and cAMP release, inhibition of cyclic
nucleotide phosphodiesterase or decreased Ca2+ may also contribute to the
vasodilatory effect of flavonoids in a manner related to the flavonoid structure
(Duarte et al., 1993). Wine, grape juice, grape skin extracts and several plant
extracts were shown to produce endothelium-dependent relaxation in vitro
mediated by the NO and through an increase in cGMP levels (Fitzpatrick et al.,
1993; Fitzptrick et al., 1995). Quercetin was shown to reduce the ai-adrenergic
receptor mediated contractile response (Ajay et al., 2006) and to enhance eNOS
activity, besides decreasing NADPH oxidase mediated superoxide generation
(Sanchez et al., 2006). Cyanidin-3-glucoside was shown to increase eNOS
expression and NO release in bovine vascular endothelial cells (Xu et al., 2004a)
and to regulate phosphorylation of eNOS and the protein kinase Akt (Xu et al.,
2004b). Delphinidin and cyanidin suppressed in vitro lipopolysacharide-induced
COX-2 expression in murine macrophages (Hou et al., 2005). Cyanidin, cyanidin
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3-galactoside and cyanidin 3-glucoside from Amelanchier fruits were shown to
inhibit in vitro COX-1 and -2 in a dose-dependent manner (Adhikari et al., 2005).
Therefore, a wild blueberry-enriched diet potentially has a positive effect on
endothelium-dependent vasodilation in the young adult SHR, via promoting NOmediated vasodilation in an antioxidant-dependent or -independent manner.
However, the beneficial effect of wild blueberries on Ach-induced vasodilation in
the young adult SHR seems to be masked by the high activity of COX-derived
vasoconstrictor factors on this genetic model of endothelial dysfunction. A longer
dietary treatment and/or a higher concentration of wild blueberries in the diet may
be necessary to elicit a beneficial effect. Furthermore, in the SHR model, a
strong genetic predisposition underlies endothelial dysfunction and therefore,

a

protective role of wild blueberries on vasodilation may be observed in a
preventive, rather than a therapeutic dietary treatment.

5.3.2. Vessel Reactivity
No significant differences in vessel sensitivity among diet groups were observed
in the young adult SHR in the absence of the inhibitors or in the presence of both
inhibitors. However, when either L-NMMA or MFA were added separately, the
vessel sensitivity in the blueberry group was higher than in the control diet group.
These findings strengthen further the hypothesis that, wild blueberries act on the
agonist receptor interactions possibly through modification of EC at the GAG
level, as previously reported (Kalea et al., 2005). Components of the EC matrix
are protected by antioxidant activity, as EC SOD has been shown to protect
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heparin/heparan sulfate (Kliment et al., 2008) and hyaluronan (Gao et al., 2008)
from oxidative fragmentation. These studies provide an explanatory link between
the antioxidant effect of wild blueberries and EC protection. It is not clear,
however, why wild blueberries exhibit this effect only when NO and COX
pathways are inhibited separately, but not simultaneously.
In comparison with age matched WK rats, the SHR aortic tissue has an
increased total GAG concentration as well as different GAG composition and
sulfation pattern, changes that have been implicated in the development of
hypertension (Risler et al., 2003). Provided the potential of wild blueberries to
alter the GAG profile in the normotensive rat to a less atherogenic one (Kalea et
al., 2005), it is possible that wild blueberries show a similar potential in the SHR.

5.4. Blood Pressure
To our knowledge this is the first attempt to study the effect of wild blueberries on
the arterial blood pressure (BP) of the young adult normotensive WK rat and
SHR. Blood pressure was directly measured in WK rats and SHR, fed a control
or blueberry-enriched diet (8% w/w) for nine weeks. Measurements of systolic,
diastolic and mean arterial BP were taken. No significant difference between the
diet groups was found in either strain of rats. Our study reveals that at the level of
8% of diet for nine weeks, wild blueberries do not have any significant effect on
the BP of young adult WK and SHR. The amount of 8% wild blueberries in the
animal diet is equivalent to half a cup of blueberries or 120 g of human daily
consumption. Several studies (Mizutani et al., 1999; Shindo et al., 2007; Duarte
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et al., 2001; Sanchez et al., 2006; Sakaida et al., 2007; Liu et al., 2003) have
revealed the hypotensive effect of isolated flavonoid components, also found in
wild blueberries, but in our study we proposed to document the effect of the wild
blueberries on BP and therefore we utilized the whole fruit.
Red wine polyphenols induced a decrease in the BP of 12 week old WK rats,
after a short term oral administration (Diebolt et al., 2001). Extract of wine
phenolics were shown to reduce BP elevation in Stroke Prone Spontaneously
Hypertensive Rat (SHRSP) after an eight-week treatment with phenolic-enriched
diet (Mizutani et al., 1999). Anthocyanins from purple corn, sweet potato and red
radish administered at the level of 1 % of diet for 15 weeks starting at the age of 5
weeks were shown to reduce BP in SHR (Shindo et al., 2007). Quercetin
administration for five weeks reduced BP and enhanced the endotheliumdependent vasodilation in response to Ach by reducing oxidative stress in the 17
week-old SHR, but not in the WK rat (Duarte et al., 2001). In addition to lowering
BP and heart rate of SHR, and enhancing endothelium-dependent vasodilation,
quercetin increased eNOS activity and decreased NADPH oxidase-mediated
superoxide generation (Sanchez et al., 2006). Blood pressure of SHR was
reduced after treatment with blueberry leaf extract, which contained 18.7%
tannins (Sakaida et al., 2007). Various tannins were shown to reduce BP in SHR,
via non-specific inhibition of angiotensin converting enzyme (ACE) (Liu et al.,
2003).

In addition, polyphenol^ compounds, such as flavan-3-ols

and

procyanidins, isolated from cocoa were found to reduce significantly ACE activity
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in vitro due to competition for enzyme-active sites with synthetic substrates rather
than a direct antioxidant effect on ACE (Actis-Gorretta et al., 2003).
Similarly to animal studies, the observations from human studies as related to BP
reduction, vary depending upon the bioactive compounds, their source, as well
as the administration dose, method and duration (McAnulty et al., 2005; Grassi et
al., 2005; Aviram et al., 2001; Aviram et al., 2004). Daily consumption of 250 g of
blueberries for three weeks did not elicit any change in the BP of chronic
smokers, although an alleviation of oxidative stress was observed (McAnulty et
al., 2005). A 15-day daily consumption of 100 g flavanol-rich dark chocolate
(88mg flavonols/1 OOg of dark chocolate)

decreased

BP and

improved

endothelium-dependent relaxation in patients with essential hypertension (Grassi
et al., 2005). In hypertensive patients, daily consumption for a two week period of
50 ml pomegranate juice, containing 1.5 mmol of total polyphenols, resulted in a
36% decrease in serum ACE and a 5% reduction in systolic BP (Aviram et al.,
2001). A reduction in BP was also observed after long term (3 years)
consumption of pomegranate juice by patients with carotid artery stenosis
(Aviram et al., 2004). The beneficial effect of pomegranate juice in BP and ACE
is attributed to their antioxidant properties.
The oxidative stress in SHR can be reduced with antihypertensive treatment
(Lazaro et al., 2005). On the other hand, the reduction of antioxidant stress can
regulate high BP. Seven-month dietary treatment of young weanling SHR with an
antioxidant diet rich in vitamins E and C, Zn and Se, reduced BP and renal
interstitial inflammation (Rodriguez-lturbe et al., 2003). Additionally, antioxidant
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drug treatment for three weeks was found to regulate BP and improve eNOS and
iNOS in vascular, renal and cardiac tissues of SHR, but not of WK rat, indicating
the contribution of oxidative stress in experimental hypertension and the
compensatory upregulation of eNOS and iNOS in SHR (Vaziri et al., 2000). In 20
to 22 week-old SHR a three-month dietary treatment with y-tocotrienol resulted in
increased NO activity and reduced BP (Newaz et al., 2003). The antihypertensive
effect of y-tocotrienol in the above study was attributed to its antioxidant-radical
scavenging properties.
Beyond any improvement in the oxidative stress, the restoration of endothelial
dysfunction does not necessarily lead to normalization of BP. The thromboxane
receptor (TP) agonist ifetroban, was shown to normalize Ach-induced relaxations
in the 16-week old SHR, however, it did not have any effect on blood pressure
(Tesfamariam and Ogletree, 1995). A 12-week treatment with 1 or 2 mg/kg/day
simvastatin, a cholesterol biosynthesis inhibitor, administered orally improved
Ach-induced

endothelium-dependent

vasodilation,

but did not elicit any

significant effect on the systolic BP in the 20 week-old SHR (de Sotomayor et al.,
1999). Similarly, an 8-week treatment with 200 mg/kg/day L-carnitine and
propionyl-L-camitine improved carbachol-induced relaxation, without preventing
the development of hypertension of the 12-week old SHR (Bueno et al., 2005).
Additionally, resveratrol dosage mimicking moderate red wine consumption, was
shown to improve endothelium-dependent relaxations to Ach in SHR after a 4week administration due to improved NO bioavailability, but did not affect systolic
BP in the SHR (Rush et al., 2007). These studies indicate that the improvement
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in endothelial-dependent vasodilation does not necessarily ensure a reduction in
BP in the SHR.
Endothelial dysfunction is not specific to essential hypertension, but instead
commonly observed in connection with the major cardiovascular risk factors (Vita
et ai, 1990; Taddei and Salvetti, 2002). Dissociation between the degree of
endothelial dysfunction and arterial BP values was indicated for human
hypertension (John and Schmieder, 2000). Moreover no correlation was detected
between BP values and endothelium-dependent vasodilation (Panza ef ai,
1993). Finally, BP reduction per se is not associated with improvement of
endothelium-dependent vasodilation (Panza et ai, 1993; Taddei and Salvetti,
2002). Hence, it is plausible that wild blueberries, despite their potential in
affecting endothelial function, do not have the ability to reduce BP in the SHR
and WK rats, at least after an 8% w/w wild blueberry enriched diet for 9 weeks.
Wild blueberries are unable to compensate for the reported impairment of the
endothelium of the SHR, which is characterized by an imbalance between
vasoconstrictors and vasodilators (Mombuli and Vanhoutte, 1999), an increased
superoxide production (Kerr ef ai, 1999) and other ROS, as well as COX-1
derived

endoperoxides

(Yang

et

ai,

2003).

Furthermore,

taking

into

consideration that bioactive compounds, also found in blueberries have shown a
positive effect on BP when studied individually or in high concentrations, the
possibility cannot be excluded that a competition of bioactive compounds in the
complex matrix of the whole wild blueberry fruit may account for the lack of any
effect on BP. A diet enriched with higher amounts of wild blueberries fed for

96

longer time may be necessary to document a significant effect on blood pressure
of SHR. This hypothesis needs to be examined with future studies.

5.5. Limitations and Future Recommendations
In the present study, we investigated the effect of a wild blueberry-enriched diet
on major vasodilation pathways and arterial blood pressure in the young adult
(21 week old) SHR and WK rat. The SHR is a model of endothelial dysfunction
and hypertension, widely used in other organ system experimental settings, but
presenting multiple metabolic defects. Their vasculature is structurally altered
due to genetically predetermined impairments, increased release and activity of
vasoconstrictors, as well as increased oxidative stress.
The dietary effect of wild blueberries was observed on the COX pathway of the
SHR, resulting in enhanced vasodilation and implying that wild blueberries exhibit
the potential to maintain arterial functional properties in this strain. Their positive
effect(s) are limited by the multiple impairments of the SHR vascular system.
Thus, these positive effects cannot extend to the level of BP either, at least at the
level of 8% of diet for a nine week period. Hence, higher wild blueberry content in
the diet or longer treatment periods can be suggested for future work. On the
other hand, studies on the effect of wild blueberries on the vasoconstrictor
pathways, would be useful in providing a complete picture of the interactions of
wild blueberry treatment with the vascular tone and the balance of vasodilatory
and vasoconstrictor substances on endothelial functions. In the same vein,
biochemical measurements of major vasodilators, NO and prostacyclin, as well
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vasoconstrictors, TXA2 and endoperoxides, can offer more insight into the
mechanism(s) that wild blueberries employ to affect vascular tone.

5.6. Significance
Considering the magnitude of the health and financial consequences of CVD,
scientific search for more effective and at the same time more affordable means
of tackling CVD has become more than a necessity. The endothelium, being the
primary site of dysfunction in all types of CVD, appears to be the ideal target for a
preventive approach. Diet is among the lifestyle modifications, along with
exercise and smoking cessation, which present the potential to maintain and/ or
restore endothelial function. Various dietary bioactive compounds have attracted
an increasing research interest over the last decade due to their acclaimed
health benefits. Among these compounds, flavonoids in particular, have been
positively associated with cardiovascular

health protection. Accumulating

evidence has documented a positive link between consumption of foods
containing bioactive compounds, also described as functional foods, and their
effect on health beyond nutrition. Wild blueberries rank high among functional
foods due to their high antioxidant capacity, as well as the plethora of bioactive
compounds they contain, which may have multiple effects on health beyond
antioxidant protection.
Our laboratory has been the first to investigate the potential role of a wild
blueberry-enriched diet on the arterial functional properties ex vivo and
specifically vasodilation, as well as the arterial blood pressure of the young adult
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SHR and its normotensive control, the WK rat. Results of the present study
demonstrate that wild blueberries can enhance vasodilation in the SHR via a
COX-pathway shift towards a reduced vasoconstrictor or increased vasodilator
profile. Wild blueberries also produced a differential activity between the two
strains, implying that their role in vasodilation depends on the state of the
endothelium, functional vs. dysfunctional. These observations are of significant
practical importance for pathological conditions with endothelial dysfunction and
may have further implications for the prevention and treatment of CVD.
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APPENDIX
Arterial Functional Property Experiments
PROTOCOL: Two Ach dose-response curves
Preload application (1,5 g for 3mm arterial ring)
Preconditioning: Ach 17 ul 10"5M (10"8M in the tissue bath)
Phe 17 ul 1fJ5M (1fJ8M in the tissue bath)
Inhibitors: MFA 17 ul 1(TM (10'5 in the tissue bath)
MFA 17 Ml 10" M

MFA

17MI10~2M

10 min
Wash out 4-5x.
5 ;„ +
Inhibitors: MFA 17 pi 10 2 M(10'°in
he tissue bath)
MFA17MH0"2M

MFA 17 Ml 10ZM

25 min
Readjust to Og.
5 min
Precontraction: Phe 17 pi 10"3M (1fJ6M in the tissue bath)
~10 min
I St

1 Ach curve
I.Ach 17uMrr 6 M (1fJ9M in the tissue bath) -6 min
2. Ach 51 pi 10"6M (3x10"9M in the tissue bath) -6 min
3. Ach 17uM0" 5 M (10"8M in the tissue bath) - 6 min
4. Ach 51 uMO^M (3x10"8M in the tissue bath) -6 min
5. Ach17MM0- 4 M(10" 7 Min the tissue bath) -6 min
6. Ach 51 Ml10"4M(3x10'7M in the tissue bath) -6 min
7. Ach17MH0" 3 M(10' 6 Min the tissue bath) -6 min
8. Ach 51 Ml10"3M(3x10"6M in the tissue bath) - 6 min
Wash out 4-5x.
Inhibitors: L-NMMA 17 ul 10"1M (1CT4 in the tissue bath)
MFA 17 ul 10' 2 M(10' 5 inthe tissue bath)
L-NMMA 17 pi 10"1M

L-NMMA 17 |jM0"1M

L-NMMA 1 7 M I 1 0 ' 1 M
MFA

25 min
Readjust to 0 g.
5 min
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17MM02M

L-NMMA 17 pi 10'1M
MFA17MM0'2M

Precontraction: Phe 17 ul 10"3M (10"6M in the tissue bath)
~10 min
2nd Ach curve
1. Ach 17 pi 10"6M (10"9M in the tissue bath) -6 min
2. Ach 51 pi 10"6M (3x10"9M in the tissue bath) -6 min
3. Ach 17 Ml 10"5M (10"8M in the tissue bath) - 6 min
4. Ach 51 Ml 10"5M (3x10"8M in the tissue bath) -6 min
5. Ach 17 Ml lO^M (10"7M in the tissue bath) -6 min
6. Ach 51 Ml lO^M (3x10 7 M in the tissue bath) -6min
7. Ach 17 Ml 10"3M (10"6M in the tissue bath) -6 min
8. Ach 51 Ml 10"3M (3x10"6M in the tissue bath) -6 min
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